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Equine embryo cryopreservation is unsuccessful in larger, more easily collected, day-7 
embryos. It is imperative that methods to successfully cryopreserve large equine embryos or 
develop reliable methods to determine embryo size before collection. Therefore the objectives 
for this study were to quantify the amount of tritiated glycerol that would permeate various sizes 
of equine embryos and to determine if circulating progesterone concentration was correlated 
with in utero embryo size. 
Mean embryo diameter (± SEM) across treatments (1.4M and 3.4M tritiated glycerol) 
was 696.5µm ± 108.6µm and 925.9 µm ± 214.1µm, respectively and were not different 
(P=0.44). The percent permeation for 1.4M and 3.4M glycerol were not different (P=0.68). 
Embryos <400 µm in the 1.4M glycerol treatment group had higher (P=0.002) permeation than 
embryos >400 µm, 8.32% ± 3.85% and 0.35% ± 0.11%, respectively. Length of time, 60 or 120 
minutes, did not affect amount of glycerol uptaken (P=0.26).  
Serum progesterone concentrations on day 7 post-ovulation were higher (P=0.009) for 
mares who produced two viable embryos from double ovulation (24.17±2.82ng/ml) compared 
with mares from which a single embryo (14.04±0.99ng/ml) was collected and control mares 
(13.53±1.80ng/ml). No differences (P=0.91) were detected in serum progesterone concentration 
on day 7 post-ovulation between mares from which a single embryo (14.04±0.99ng/ml) was 
collected and control mares (13.53±1.80ng/ml). Mares producing embryos >400µm tended to 
have higher (P=0.08) circulating progesterone concentrations than mares producing embryos 
<400µm. Serum progesterone concentrations day 7 post-ovulation in mares producing embryos 
>400µm and <400µm were not different (P=0.61 and P=0.68, respectively) than control mares. 
Single embryos <1000µm in diameter were correlated with circulating progesterone 
concentration day 7 post-ovulation (r=0.46, P=0.006). There was no significant correlation 
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between embryo diameter, corpus luteum diameter, and serum progesterone concentration day 
7 post-ovulation. 
 This is the first study to quantify the amount of glycerol permeating into equine 
blastocysts and suggests that the capsule may be a barrier to cryoprotectant permeability. 
Maternal progesterone concentrations day 7 post-ovulation could be utilized in predicting 
embryo stage and size prior to collection for cryopreservation and in diagnosis of twin 







Embryo transfer has made a remarkable change in the way female genetics are 
disbursed in all species in the livestock industry. The ability to cryopreserve embryos allows 
genetics to be imported and exported worldwide and to be retained prior to loss of fertility or 
death. Embryo cryopreservation reduces the labor and cost involved with synchronizing embryo 
collection to coincide with transfer to a recipient female. 
Compared with embryos of other domestic species, the equine embryo has unique 
differences that could contribute to cryopreservation failure. Early blastocysts and blastocysts 
have a much shorter cell cycle (6 hours) (Colchen et al., 2000; Moussa et al., 2005) resulting in 
a greater number of cells and increased in diameter than embryos from other domestic species  
at the same developmental stage (Bruyas et al., 1993; Moussa et al., 2005). Cells of equine 
early blastocysts and blastocysts also contain large vesicles and large amounts of lipids stored 
in variably-sized droplets that make them difficult to cryopreserve (Flood et al., 1982; Bruyas et 
al., 1993). Equine early blastocysts also develop a capsule (acellular glycoprotein layer) 
between the zona pellucida and trophoblast cells after entering the uterus (Oriol et. al., 1993a). 
This process is unique to the equine species. 
Two methods, slow freezing and vitrification, allow the cryopreservation of only small 
equine embryos (<300µm) (Hochi et al., 1994; Bruyas et al., 2000b; Lascombes and Pashen, 
2001). Currently, equine embryos that are collected for cryopreservation at the morula stage 
possess either no capsule or an incomplete capsule. These embryos can be successfully frozen 
in glycerol, similar to bovine embryos (Bruyas et al., 2000b).  
Studies have suggested that the capsule may impede permeation of cryoprotectants to 
the embryo proper resulting in osmotic injury to the inner cell mass during the freezing and 
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thawing process resulting in inadequate concentration of cryoprotectant in the blastocoele 
(Slade et al., 1985a; Legrand et al., 1999a; Bruyas et al., 2000a). It has been reported that there 
is a negative correlation between capsule thickness and freezability of equine embryos 
(Legrand et al., 2000).  
Monitoring serum progesterone (P4) concentrations has been a routine practice for 
determining phases of the estrous cycle or pregnancy in mares. Pregnancy loss occurs in 10 to 
15% of mares during gestation and the majority of these losses occur during the first 40 days of 
pregnancy (Allen et al., 2001b).  The pregnancy is most vulnerable at this stage because the 
primary corpus luteum is the sole source of progesterone. It has been reported that the primary 
corpus luteum should produce systemic blood concentrations of progesterone >4ng/ml the first 
3 weeks of pregnancy (Ball et al., 1988).  
Exogenous progesterone supplementation provided to ovariectomized embryo transfer 
and pregnant mares after luteolysis induction has been reported to save and positively stimulate 
mobility, fixation, orientation, and prevent early embryonic loss (Kastelic et al., 1987). In this 
study, it was also demonstrated that embryos could be rescued by progesterone 
supplementation up to 4 days after prostaglandin treatment. Results from these studies 
demonstrate the importance of progesterone in embryo-uterine interactions in early equine 
pregnancy. 
Rambags (2008) describe detection of mRNA for an equine membrane associated 
progesterone receptor (mPR), intracellular progesterone receptor (PR), and intracellular 
estrogen-β receptors (ERβ). This suggests that maternal estrogen and progesterone stimulates 
the conceptus to synthesize factors that may play a role in maternal recognition and continued 
luteal function during early pregnancy 
We propose the day 7 blastocysts are impermeable to cryoprotectant penetration into 
the embryo proper. Therefore this study was conducted to quantify the amount of glycerol that 
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permeates into the embryo of encapsulated day 7 equine blastocysts, using slow-cool (1.4M 
glycerol) and vitrification (3.4M glycerol) concentrations of glycerol3H. We also compared 
permeabilities of embryos with an incomplete or a very thin capsule (<400µm) to those 
possessing a fully developed, functional capsule (>400µm). Also, the use of maternal serum 
progesterone concentration to estimate embryo size would be beneficial in determining the 
proper collection time for equine embryos destined for cryopreservation and transfer. Therefore, 




















2.1 Equine Estrous Cycle 
The normal estrous cycle of the mare is approximately 21 days, and the normal length of 
estrus and the inter-estrous interval range from 5 to 7 days and from 14 to 16 days, respectively 
(Ginther, 1992). Individual variations in estrous cycles exist and can be dependent on seasonal 
influences, body condition, number of follicular waves, lactation, and the possibility of multiple 
diestrus ovulations (Robinson, 2003).  
 The predominant hormone during behavioral estrus is estradiol. At this time 
progesterone is minimal (less than 1 ng/ml), this allows mares to show signs of estrus such as 
winking of the clitoris, standing for a stallion, and frequent urination (Youngquist and Threfall, 
2007). As the dominant follicle continues to grow, GnRH and LH are produced with the gradual 
decrease in FSH. These changes cause estradiol production to decrease prior to ovulation. This 
decline in estradiol corresponds with the end of behavioral estrus. Ovulation usually occurs 1-2 
days before the end on behavioral estrus. The end of one estrous cycle and the beginning of 
another are marked by ovulation (day 0). 
 Multiple ovulations can occur in mares and there appears to be an individual 
predisposition for this phenomenon. Maiden and barren mares are more prone to ovulate 
multiple follicles than lactating mares (Henry et al., 1982), and it is postulated that double 
ovulations occur because of an increased number of LH receptors on two developing follicles, 
this in turn causes an increased sensitivity to gonadotropins (Ginther, 1992). There may also be 
a hereditary predisposition for double ovulations as is a common occurrence in draft mares 




Once ovulation occurs, diestrus begins and is evident by cessation of estrous behaviors. 
The dominant hormone during this stage of the estrous cycle is progesterone. Blood levels of 
progesterone increase rapidly following ovulation, leveling off around day 7 post-ovulation. 
GnRH pulses become infrequent and FSH pulse amplitude increases relative to LH (McKinnon 
and Voss, 1993). Blood concentrations of FSH reach their maximum during diestrus which 
encourages follicular growth.  
 During diestrus one or two follicular waves may occur (Ginther, 1990). If there is only 
one follicular wave, than it is the primary wave of folliculogenesis. The primary wave begins 9 
days post-ovulation. In two wave mares, a dominant anovulatory follicle will grow and begin 
regression 9 days post-ovulation. At this time the primary wave will begin growth and dominant 
follicle will ovulate ~20 days post-ovulation. During these processes the granulosa and theca 
cells of the dominant follicle begin to produce inhibin in combination with small amounts of 
estradiol which causes FSH to decline and subordinate follicles to undergo atresia (Ginther, 
1990).  
The gradual increase in LH during late diestrus is a product of the regression of the CL 
and a decrease in the negative feedback of progesterone (Pattison, 1974). Recent research 
suggests that the increase in LH is held at an intermediate level by the attenuating effect of 
increasing but intermediate concentrations of estradiol until late diestrus (Ginther et al., 2007).  
By the end of diestrus the endometrium in primed by progesterone and begins to secrete 
PGF2α (Douglas et al., 1972). At day 14 post-ovulation PGF concentrations peak and luteolysis 
and subsequent decline in progesterone occur. Mares return to estrus 1 to 3 days following CL 
regression with ovulation occurring 5 to 7 days later.  
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2.2 Equine Embryo Transportation to the Uterus 
 After ovulation, the mare’s oocyte is released through the ovulation fossa into the 
oviductal fimbria and progresses to the ampullary region of the oviduct where, if capacitated 
sperm are present, fertilization will occur (Boyle et al., 1987; Hunter, 2005). During the next 72 
hours the newly formed zygote will reach the two cell, four to six cell, and eight to ten cell stage 
at 24, 48, and 72 hours post-ovulation, respectively (Bezard et al., 1989). 
 A unique characteristic of equine oviductal transport is the ability to identify and transport 
only developing viable embryos independently from unfertilized oocytes. Niekerk and Gerneke 
(1966) first demonstrated the differential transport of embryos and oocytes. Unfertilized oocytes 
(UFOs) become lodged in the ampulla and slowly degenerate (Niekerk and Gerneke, 1966). It 
has been reported that occasionally UFOs will be transported through the oviduct and into the 
uterus with a viable embryos (Freeman et al., 1992). 
 A series of experiments explained the reason for this unique transport involving recovery 
and culture in vitro of early stage embryos (Weber et al., 1991a; Freeman et al., 1992) and 
surgical implantation of hormone secreting minipumps onto the mesosalphinx of mares at 
various time after ovulation (Weber et al., 1991b; Weber et al., 1992). These experiments 
verified that the embryo secretes prostaglandin E2 (PGE2) at the morula stage, whereas the 
oocyte does not. Weber proposed that the embryo lodges at the ampullary-isthmus junction as a 
result of the contraction of the smooth muscle (day 4-5 post-ovulation) (Weber et al., 1995). 
PGE2 then begins to be secreted and relaxes the smooth muscle fibers in the wall of the oviduct 
which allows the rapid movement and entry of the embryo into the uterus (Weber et al., 1995).   
2.2.1 Effects of Progesterone 
 Progesterone is an important hormone during oviductal development and uterine 
synchrony in many species. It has been reported that embryos from domestic animals can 
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develop in vitro without the supplementation of progesterone (Eyestone and First, 1989; White 
et al., 1989). In mice, progesterone is necessary for normal development and transport of 
embryos through the oviduct (Roblero, 1973; Roblero and Garavagno, 1979).  
 Administration of the antiprogestin compound RMI 12,936 has been shown to cause an 
arrest in embryo oviductal transport when given on day 1, 2, or 3 post-ovulation in mice (Kendle 
and Lee, 1980). However, this effect can be reversed if antiprogestin is administered on day 1 
post-ovulation and then the female is treated with progesterone 24 to 48 hours later. These 
results verify that in the mouse embryo oviductal transport is mediated by progesterone and 
requires a continuous source of progesterone to maintain transport. 
 These oviductal transport requirements have also been reported in the rat. Forcelledo 
(1982) ovariectomized, adrenalectomized, or ovariectomized and adrenalectomized pregnant 
rats on days 1 to 3 post-ovulation. Embryos from the ovariectomized group exhibited no 
transport until progesterone implants restored serum progesterone levels to normal 
concentrations. The adrenalectomized group exhibited normal transport. Conclusions from this 
study were that secretion of progesterone from the ovaries plays a major role in regulation of 
oviductal embryo transport and that progesterone secretion from the adrenal glands is not 
essential and can not substitute for the ovarian progesterone source.  
Fuentealba (1988) continued work on this hypothesis and concluded that oocyte 
transport in pregnant rats took 24 hours longer than nonpregnant embryo transfer recipients. 
Further investigation of the role of progesterone and estrogen oviductal receptors and plasma 
concentrations showed that the action of estrogen on the timing of oviductal egg transport in 
pregnant rats is controlled by endogenous progesterone (Fuentealba et al., 1988). 
In cattle, ovum transport through the ampulla is rapid; however, transport of embryos 
through the isthmus into the uterus is delayed and results from muscular contractions (El-Banna 
and Hafez, 1970). It was demonstrated in this same study that embryos of super-ovulated 
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Hereford females reached the uterus by 72 hours post-ovulation and were at the eight cell 
stage. The oviducts were measured and divided into 8 equal segments with segment 1 being 
closest to fimbriae. In untreated single ovulating females, embryos were in segment 6 of the 
oviduct by 72 hours. All embryos that did not develop became lodged in the ampullarary region 
of the oviduct and were not transported further. This study agrees with Oxenreider and Day 
(1965) who showed rapid oviductal transport of embryos in pigs. The rapid transport of embryos 
in the pig and super-stimulated cattle is attributed to large number of corpora lutea, high 
progesterone concentrations, and estrogenic effects. 
 More recently, it was proposed that early progesterone administration in the cow could 
alter the ratio of PGE2 to PGF2α synthesis in the uterus to favor and facilitate PGE2, furthermore 
stimulating oviductal transport (Mann and Lamming, 2001).  
Hinrichs and Watson (1991) demonstrated that administration of 250 mg of exogenous 
progesterone in mares on days 0, 1 and 2 post-ovulation did not hasten embryo transport to the 
uterus by day 5 post-ovulation. Ball (1992) later reported that 450 mg of exogenous 
progesterone administered to mares on days 0 to 6 post-ovulation did not affect embryonic 
development as determined by evaluation of morphologic evaluation, size, and number of cell 
nuclei of embryos recovered from the uterus at day 7 post-ovulation. However, to properly test 
the hypothesis embryos should be collected upon entry into the uterus (day 5 post-ovulation) to 
evaluate the effects of progesterone on the development and transport of oviductal embryos. 
2.3 Uterine Equine Embryo Development 
The equine embryo enters the uterus between 144 to 156 hours (6 to 6.5 days) post-
ovulation at the morula/early blastocyst stage (Allen, 2001a). After arriving in the uterus, the 
equine early blastocyst begins to form an acellular glycoprotein “tertiary embryo coat,” known as 
the blastocyst capsule (Flood et al., 1982). The capsule first appears between the 
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trophectoderm and the zona pellucida of the late morula/early blastocyst stage embryos (Stout 
et al., 2005). The blastocyst then expands rapidly and hatches from its zona pellucida and is  
fully enveloped in a complete capsule; at this stage (day 7 post-ovulation) the embryo contains  
a few thousand cells (Tremoleda et al., 2003) and is approximately 250µm (Betteridge et al., 
1982).  
Equine embryo morphology has been shown to be predictive of the potential for the 
transfer of that embryo to result in a sustained pregnancy (Carnevale et al., 2000). In this study 
embryos that possessed a lower grade, resulted in  lower pregnancy rates than embryos of a 
higher grade regardless of synchrony of recipient.  
During the next 7 days the conceptus continues to grow rapidly reaching 3 to 5 mm in 
diameter (>45,000 cells), on day 10 post-ovulation (Betteridge et al., 1982). The equine 
conceptus grows at a rate of 3.4 mm per day from days 11 to 16 post-ovulation (Ginther et al., 
1983).  This growth is a result of yolk sac fluid accumulation (Betteridge et al., 1982) and as a 
result the capsule increases in size and dry weight, which serves as the protective envelope 
around the conceptus (Oriol et al., 1993b).  
The blastocyst cavity becomes lined with primitive endoderm to form a true “yolk sac” 
during this same period (Enders et al., 1993). The small ICM then expands and develops to 
form the bi-layered embryonic disc (trophectoderm and yolk-sac endoderm). Between days 10 
and 12, the embryonic disc becomes macroscopically visible and around day 12 the primitive 
streak, precursor to embryo proper, becomes microscopically visible (Ginther, 1979). Cells then 
migrate through the primitive streak and differentiate to create mesoderm (gastrulation), which 
begins the formation of a recognizable multicellular embryo (Enders et al., 1993; Betteridge, 
2000).  
Hershman and Douglas (1979) demonstrated that if a pony embryo were present at day 
15 of gestation, but was then removed non surgically, the next ovulation would be delayed for 
10 
 
several weeks. If the embryo was removed on day 14 of gestation the duration of the normal 
estrous cycle was not affected with luteolysis initiated on day 16 with and subsequent estrus 
and ovulation. 
A plateau of growth occurs between day 18 to 26, after which conceptus growth 
continues at a rate of 1.8 mm per day until day 50 (Ginther, 1983).  The endodermal wall of the 
yolk sac is completed from cells that are broadly distributed around the interior of the blastocyst, 
and seem to have other unusual characteristics (Enders et al., 1993). The fetal membranes and 
circulatory system develop to an extent before the first signs of a functional yolk sac 
(choriovitelline placenta) at day 22 (Enders et al., 1993) 
 At three weeks, the spherical embryo is surrounded by a single layer of trophectoderm 
and the allantois is beginning to form. The highly vascularized embryo enlarges at the 
embryonic pole between days 21 and 40, while the yolk sack regresses to the opposite pole 
(Amoroso, 1952). Specialized chorionic girdle cells form around the embryonic vesicle between 
days 25 and 35 (Allen and Moor, 1972). These cells detach at day 38 and invade the uterine 
endometrium to form endocrine glands (endometrial cups) that produce equine chorionic 
gonadotropin (eCG) between days 40 and 130 of gestation (Allen et al., 1973; Allen, 1975). 
 Cole et al. (1931) reported the close relationship between the secretion of eCG and the 
considerable degree of secondary luteal development that occurs on the mare’s ovaries 
between days 40 and 150 days of gestation. It has been suggested that eCG stimulates the 
luteal cells of both primary and secondary corpora lutea to secrete both progesterone and 
estrogen (Sirois et al., 1990; Daels et al., 1998).  
2.3.1 Effects of Progesterone 
The mechanisms that prevent luteolysis and maintenance of early pregnancy are not 
completely understood. It is a gradual process and involves down-regulation of oxytocin 
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receptors in the endometrium so that releases of PGF2α from the endometrium are prevented 
(Sharp et al., 1997). 
Dawson (1977) reported that progesterone concentrations in plasma reach a peak of 8 
to 15 ng/ml between days 6 and 14 after ovulation and then decline steadily to between 4 to 6 
ng/ml at days 30 to 35 of gestation. There is evidence of resurgence of the primary corpus 
luteum, starting on day 35 of gestation, which is believed to be in response to the release of 
eCG by the endometrial cups (Bergfelt et al., 1989). There is a further rise which occurs with the 
development of the first of the accessory corpora lutea, with concentrations of 8 to 25 ng/ml 
being maintained until day 150 when both primary and secondary corpora lutea begin to regress 
(Bergfelt et al., 1989).   
Mares, more than pregnant females of any other species are administered progesterone 
or progestins during part or all of their pregnancy due to fear of luteal insufficiency during 
pregnancy. Pregnancy loss occurs in 10 to 15% of domestic species during gestation and the 
majority of these losses occur during the first 40 days of pregnancy in the mare (Allen, 2001b).  
The pregnancy is most vulnerable at this point because the primary CL is the sole source of 
progesterone. The primary corpus luteum should produce systemic blood concentrations of 
progesterone >4ng/ml the first 3 weeks of pregnancy (Youngquist and Threfall, 2007). 
McKinnon demonstrated that ovariectomized recipient mares can be used for embryo transfer 
when supplemented with a minimum dose of 0.044 mg/kg of body weight of altrenogest until 
endometrial cup formation (McKinnon et al., 1988), verifying that progesterone is necessary to 
maintain pregnancy.  
Progesterone supplementation in ovariectomized and pregnant mares in which luteolysis 
was induced has been reported to save and positively stimulate mobility, fixation, orientation, 
and prevent early embryonic loss (Kastelic et al., 1987). In this study it was also demonstrated 
that embryos could be rescued by progesterone supplementation up to 4 days after 
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prostaglandin treatment. These results demonstrate the importance of progesterone in embryo-
uterine interactions in early equine pregnancy and agree with previous findings (Ginther, 1985). 
Papa (1998) attempted to find predictive attributes of early equine pregnancy to 
determine causes of early embryonic death. In this study embryonic losses occurred on day 19 
(47%) and day 21 (29%) post-ovulation and agree with results report by Bergfelt et al. (1992). 
The mean diameter and progesterone values did not differ between pregnant and non-pregnant 
(early embryonic death) groups, showing that progesterone decrease is the result of and not the 
cause of early embryonic death. These researchers also reported that there was no correlation 
between corpus luteum diameter and maintenance of gestation. However, the mean plasma 
estrogen concentration and embryo vesicle diameter were higher in pregnant mares, which 
could be indicators of embryo viability.  
Lane et al. (2001) demonstrated that equine morulae use equal amounts of pyruvate and 
glucose as energy sources; glucose consumption then increases exponentially as the embryo 
begins to blastulate. It has been demonstrated by Bruck (1997), that progesterone induced 
endometrial proteins can stimulate glucose metabolism and therefore growth of the blastocyst. 
These studies suggest that higher progesterone during blastulation is important to embryonic 
growth. 
Recently, the effects of mare age and altrenogest treatment on conceptus development 
and secretion of hormones in early pregnancy has been investigated (Willmann et al., 2011). In 
this study, mares were divided into two treatments according to age (4 to 8 years and >8 years) 
and received either altrenogest (0.044 mg/kg once daily) or sunflower oil (control) from days 6 to 
100 of pregnancy. There was no difference in sustained pregnancy rate between treatments. 
Altrenogest treatment had no effect on mean diameter of the embryonic vesicle between days 
12 to 22 of pregnancy. There was a significant effect of mare age and altrenogest treatment on 
the size of the embryo proper between days 30 and 45 of pregnancy. Older mares exhibited 
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smaller vesicles when compared to those collected from younger mares.  In the control group 
embryo size was negatively correlated with the age of the mares (day 30: r = -0.834, P<0.05). 
This is a critical phase of pregnancy and corresponds with the completion of organogenesis and 
the beginning of placentation. This study demonstrates for the first time the positive influence of 
altrenogest treatment on retarded development of the embryo around the beginning of 
placentation in mares older than 8 years. 
Administration of exogenous progesterone has been reported to increase fetal weight 
and crown rump length in ewes (Kleemann et al., 1994). Early evidence indicates that 
progesterone treatment changes cell lineage differentiation in sheep with differences in the 
proportion of inner cell mass and trophectoderm cell number (Hartwich et al., 1995). It has also 
been reported that there is a proportionate increase in fetal growth when ewes were 
supplemented with exogenous progesterone in early pregnancy; specifically kidney, spleen, 
total gut, head width, and thorax circumference and a disproportionate increase in brain, heart, 
and tibialis anterior weight (Kleemann et al., 2001). These authors also reported that response 
to progesterone treatment did not occur when treated the first three days of pregnancy. 
Embryos responded to progesterone treatment day 3 post-ovulation when the uterus becomes 
progesterone-primed.  
Similar studies have been conducted in the cattle and it was reported that by increasing 
progesterone from day 1 to 4, embryo development on day 14 was advanced (10 fold increase 
in conceptus length) (Garrett et al., 1988). Kerbler (1997) demonstrated a slight increase in 
interferon-τ production on day 18 bovine embryos collected from cows that were supplemented 
with progesterone on day 8 of pregnancy by induction of accessory corpus lutea. Conclusions 
from these studies are that it is the post ovulatory progesterone rise and not the level of 
progesterone secretion achieved that is most important in the control of embryo development in 
the cow. This is supported by a study in which progesterone was supplemented exogenously 
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from day 5 to 9, but not from day 12 to 16 post-ovulation which resulted in a six fold increase in 
the uterine concentration of interferon-τ and a fourfold increase in trophoblast length on day 16 
of pregnancy (Mann et al., 2006).  
It has been demonstrated in ferrets that passive immunization with a heterologous anti-
progesterone monoclonal antibody arrests embryonic development during early pregnancy 
(Rider and Heap, 1986). The results indicate that the normal course of pregnancy is arrested as 
a result of antibody binding of progesterone in the circulation, causing a decrease in the amount 
of progesterone available to target cell receptors, and therefore blocks normal cleavage and 
embryonic development at an early stage. 
2.4 Equine Capsule Function and Effects 
 The equine embryo enters the uterus between 6 to 6.5 days post-ovulation (Battut et al., 
1997) at the late morula or early blastocyst stage completely enveloped in the zona pellucida 
(Betteridge et al., 1982). During the beginning of blastulation, an acellular glycoprotein capsule  
forms between the trophectoderm and zona pellucida (~6.5 days post-ovulation) (Betteridge et 
al., 1982). As blastulation continues and the embryo begins to rapidly expand this causes the 
zona pellucida to decrease in thickness, and eventually rupture to allow the blastocyst that is 
now completely enclosed in its capsule to hatch (Flood et al., 1982). The blastocyst capsule  is 
formed primarily by the trophoblast cells and is composed of a mucin-like glycoprotein (Oriol et 
al., 1993b). Evidence of mRNA from the mucin gene MUC1 in both the trophoblast and 
endometrium cells suggest that the endometrium could also contribute to the formation of the 
capsule (Gillies et al., 1999).  
Hochi (1995a) attempted to produce equine capsule material in vitro by collecting 
embryos day 6 post-ovulation and culturing for 5 days in various TCM-199 media. Embryos 
hatched from their zona pellucida and/or capsule layer at different times depending on the 
medium the embryos were cultured in. Hatching from capsule layers prematurely was caused 
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by poor capsule integrity of the cultured embryos. This study demonstrated the importance of 
blastocyst and uterine environment interaction during early development is instrumental in 
capsule development. 
A more recent study (Albihn et al., 2003) utilized endometrial biopsy samples and 
conceptuses from six mares between days 13 to 15 after ovulation. Biopsies were prepared as 
1 mm3 grafts of endometrium, trophoblast and capsule material for transplantation, alone or in 
combination, into various sites in 88 immunodeficient mice to identify the true source of capsular 
production. Capsular material was produced from grafts of trophoblast material (both alone and 
in combination with endometrium graft on the same mouse) but not from mice with grafts of 
endometrium alone. These results suggest that the trophoblast may be the principal source of 
equine embryonic capsule formation. In addition, they demonstrate that xenogeneic grafting is a 
useful means of culturing endometrium and conceptus tissues outside the mare when in vitro 
techniques do not suffice. 
The capsule is thought to provide at least three vital functions (Allen and Wilsher, 2009). 
First, the capsule is a pliable, elastic, strong structure providing protection from myometrial 
contractions and facilitating transuterine migration throughout the lumen before fixation 
(Betteridge, 1989). When equine blastocysts were capsule-denuded and transferred into its 
original uterus, capsule regeneration did not occur and embryos did not survive, showing that  
capsule formation is a stage specific event and necessary to maintain pregnancy (Stout et al., 
2005). Second, it also appears to be instrumental in maintaining the conceptus in a spherical 
shape during early pregnancy, a feature that is very different from the elongation of other 
domestic embryos (Allen and Wilsher, 2009). Maintenance of its spherical shape and prolonged 
period of uterine migration are linked to suppression of PGF2α secretion by the endometrium 
and maternal recognition of the equine conceptus (McDowell et al., 1988). Third, the high 
concentration of negatively charged sialic acid residues within its constituent glycoproteins 
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(Oriol et al., 1993a) may function to provide an anti-adhesive effect and both regulate the 
embryo’s intrauterine movement and assist in the accumulation and uptake of endometrial gland 
exocrine secretions (uterine milk) (Allen and Wilsher, 2009). These secretions contain the 
transport proteins uterocalin (Stewart et al., 1995) and uteroglobin (McDowell et al., 1990) that 
are the principal source of nutrients for the still unattached conceptus during the first 40 days of 
pregnancy. The capsule also acts as a “mailbox” for proteins and other molecules being 
exchanged between the conceptus and endometrium during early pregnancy (Crossett et al., 
1998; Herrler and Beier, 2000).   
It has also been suggested that the capsule plays an indirect role in fetal-maternal 
signaling during early pregnancy by storing conceptus produced insulin-like growth factor 
binding protein-3 (IGF-BP3) (Herrler and Beier, 2000), and the endometrially secreted lipocalin 
uterocalin (P19) (Crossett et al., 1998), both of which play direct roles in maternal-fetal dialogue.  
Before fixation, the yolk-sac wall contains large amounts of GM2-activator protein 
(GM2AP). This protein plays a role in transport of glycolipids or phospholipids while the capsule 
is still intact (Quinn et al., 2006). At the time of fixation sialic acid is lost from the capsule. This 
loss does not occur if the mare is treated with PGF2α at day 14 post-ovulation (Chu et al., 1997). 
The loss of sialic acid in the capsule reduces the number of exposed negatively charged 
galactose and N-acetylgalactose residues of the major core type 1 O-glycan (Arar et al., 2007), 
which could be associated with changing the permeability of the capsule. It is believed that 
changes in charge could be involved in the mechanism(s) of conceptus attachment to the 
endometrium. After fixation capsule production declines until it ruptures on day 21 through 
enzymatic mechanisms that still remain unclear (Denker, 2000).   
The capsule has been thought to be a cause of lower success of freezing large embryos 
(>300µm) utilizing various freezing protocols. Early work by Pfaff (1993) demonstrated that 
smaller embryos were more permeable to the cryoprotectants glycerol and ethyl glycol by 
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placing embryos in each respective cryoprotectant solution and measuring volume and 
equilibration times. When placing embryos in hyperosmotic cryoprotectant solutions water exits 
the embryo (volume decreases) and cryoprotectants and water enter the embryo until 
equilibrated (volume increases to original size) via osmosis (Leibo and Songsasen, 2002). Pfaff 
(1993) reported that larger embryos (>500 µm) didn’t equilibrate in glycerol solution after 10 
minutes and continued to lose volume after 20 minutes. This effect was most likely caused by 
higher cryoprotectant concentration extracellulary than intracellularly, caused by cryoprotectant 
not entering the embryo proper. All embryos treated with ethylene glycol had higher (P<0.01) 
volumes than embryos treated with glycerol suggesting the equine blastocysts are more 
permeable to ethylene glycol, though there was little penetration in larger blastocysts (Pfaff, 
1993). 
Legrand (2000) studied the permeability of the equine capsule, using a classical 
freeze/thaw procedure. After thaw and culture embryos were fixed and embedded in Epon 812 
and serial sectioned into semi-thin sections (1 µm), every fifth section was stained with 0.5% hot 
toluidine blue and evaluated with light microscopy. Capsule formation and cell nuclei were 
evaluated and categorized. Researchers found the rate of dead cells after thawing was directly 
proportional to the capsule thickness. Embryos exhibiting a thick capsule possessed more 
damaged cells as a result of the freeze-thaw process, compared with embryos with little or no 
capsule. A negative correlation between capsule thickness and freezability of large embryos has 
been demonstrated in other studies and suggests that the capsule may impede penetration of 
cryoprotectants into the embryo proper (Bruyas et al., 2000a; Legrand et al., 2000). 
Legrand (2001) tested this hypothesis by immersing expanded blastocysts in trypsin 
prior to freezing to permeabolize the capsule. In this study eight embryos were transferred and 
resulted in six pregnancies. This study was replicated twice and resulted in reduced  pregnancy 
rates when compared with the original study, 3/11 (Legrand et al., 2002) and 0/14 (MacLellan, 
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2002). It has been reported that trypsin treatment may disrupt the embryo’s cytoskeleton during 
freezing process and also increases the adhesive properties of the capsule (Tharasanit et al., 
2005). 
2.5 Synthesis and Secretion of Equine Uterine Proteins, Receptors, and Growth Factors 
For development of embryos to continue the embryo must alter the pattern and/or 
amount of PGF2α secreted by the endometrium (Bazer et al., 1998). In cattle (Bazer and 
Thatcher, 1997), sheep (Bazer and Thatcher, 1997) and pigs (Bazer et al., 1998) the 
antiluteolytic signal originates from the conceptus and acts on the endometrium to suppress 
PGF2α production. This antiluteolytic signal varies between species. Cows and ewes secrete 
type-1 interferon, (interferon-τ), whereas sows secrete estrogen (Bazer and Thatcher, 1977; 
Bazer et al., 1998). In the mare the preimplantation period is long, which has a non-invasive 
epitheliochorial placenta that does not fully implant until day 40 post-ovulation (Samuel et al., 
1974). The nature of embryonic signal for maternal recognition in the mare remains a mystery. 
The mare is unique in that the developing conceptus remains spherical and mobile until fixation 
at day 17 post-ovulation (Ginther, 1983).  
Major secretory products that have been identified during early pregnancy include 
steroids, eicosanoids, proteins, and peptides (Simpson et al., 1999). The first published instance 
of equine conceptus steriodogenesis was in the 1970’s indicating production of estrogens and 
androgens (Flood et al., 1979). Goff (1993) reported that 17α-hydroxyprogesterone, not 
estradiol, is the major steroid synthesized by the equine conceptus between 7 to 14 days post-
ovulation. This study also suggested that this steroid is further metabolized to an unidentified 
steroid by the endometrium and it is thought that these steroids could play a role in conceptus 
development and prevention of luteolysis.  
Recently, coexpression of two equine genes (EqIFN-δ1 and EQIFN-δ2) coding for a 
protein similar to interferon (INF) family which is the bovine, ovine and porcine signal for 
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maternal recognition (Cochet et al., 2009). EqIFN-δ1 and EqIFN-δ2 genes are expressed during 
days 16 to 22 of pregnancy (Cochet et al., 2009) which coincide with the critical time of early 
embryonic loss in the mare. The direct effects of progesterone and/or progesterone 
supplementation have yet to be studied on EqIFN-δ1 and EqIFN-δ2. 
There are numerous progesterone-dependent proteins that have been reported to be 
produced by the uterus, many of which are vital to the nutrition of the equine conceptus 
(Betteridge, 2000). Acute loss of these proteins occurs with luteolysis (Zavy et al., 1979b). The 
first progesterone dependent uterine protein studied in detail is uteroglobin. Uteroglobin was first 
identified as a low molecular weight uterine protein secreted by rabbits and is the founder of the 
secretoglobin superfamily of proteins (Beier, 1968). Subsequently the gene coding for the 
uteroglobin gene was found in humans (Singh et al., 1988), rats (Nordlund-Möller et al., 1990), 
mice (Ray et al., 1993), hamsters (Sagal and Nieto, 1998b), pigs (Sagal and Nieto, 1998a), and 
mares (Beier-Hellwig et al., 1995).  
In the mare, uteroglobin is a major endometrial progesterone–dependent secretory 
protein that is found in uterine secretions during the luteal phase (Beier-Hellwig et al., 1995); 
however, it has also been detected by northern blot analysis in the lung, uterus and prostate 
gland in horses (Müller-Schöttle et al., 2002). This protein has a small lipophilic binding pocket 
(von der Decken et al., 2005) and can bind eicosanoids such as PGF2α which could influence 
endometrial receptivity and blastocyst implantation (Mukherjee et al., 2007). Anti-inflammatory 
and anti-chemotactic properties have also been suggested (Mukherjee et al., 2007). In rabbits 
uteroglobin has been shown to protect trophoblastic cells from the immune defense system of 
the mother by impairing migration of phagocytes and subsequent rejection (Vasanthakumar et 
al., 1988).  
The best characterized equine progesterone-dependent lipocalin is P19 (uterocalin) 
which transports small, hydrophobic molecules such as steroids and eicosanoids through the 
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glycan capsule and into the yolk sac of the conceptus (Stewart et al., 2000b). Early studies 
determined that uterocalin is taken up by the blastocyst capsule (Stewart et al., 2000b), and 
transports vital vitamins and minerals to the embryo proper (Crossett et al., 1998). Uterocalin is 
a highly cationic protein (pI~9.4), this property explains why it readily binds to the equine 
capsule (Hayes et al., 2008). Uterocalin is secreted by endometrial glands in the luteal stage of 
the ovarian cycle and in the first 25 days of a pregnancy, and production ceases around the 
time of capsule deterioration (Stewart et al., 2000b; Suire et al., 2001; Kennedy, 2005).  Stewart 
(2000b) demonstrated that uterocalin remains detectable in the endometrial glands of pregnant 
mares and in the trophoblast cells overlying these glands as late as day 250 of pregnancy. 
Uterolcalin is secreted asynchronously in older mares with endometrosis and this may 
contribute to early embryonic death (Stewart et al., 2000a; Hoffmann et al., 2003). Amounts of  
uterocalin detected in uterine flushes of pregnant mares was lower with pretreatment of PGF2α, 
indicating the progesterone dependence of this protein (Suire et al., 2001). 
 Uteroferrin is another progesterone-dependent protein found in uterine secretions of the 
mare; however it was originally characterized and is very similar to the pig with purple 
coloration, acidic phosphatase activity, and a molecular mass of 35 kDa (McDowell et al., 1982). 
Various studies have demonstrated that the equine placental transport system for iron and its 
carrier protein uteroferrin is always membrane-bound in vesicles or lysosomes of maternal 
epithelium or columnar cells of the trophoblast (Wooding et al., 2000, 2001).  
The equine conceptus produces PGE2 following its passage from the oviduct to the 
uterus, with peak production between 11 to 15 days post-ovulation (Vanderwall et al., 1993). 
Watson and Sertich (1989) reported that 14 day old horse embryos in culture release PGF2α, 
PGE2 and PGI2 (measured by the stable metabolite 6-keto-PGF-la). Embryos of other species 
are known to produce prostaglandins (Hyland et al, 1982; Hwang et al, 1988) and are thought to 
make a significant contribution to the uterine milieu in maternal recognition of pregnancy. 
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However, concentrations released by the embryos in the present study were very low compared 
with concentrations released by the endometrium. (Watson and Sertich, 1989). 
Merkl (2010) used microarray analysis of endometrial biopsies from both non-pregnant 
and pregnant mares. This study revealed no detectable changes in gene regulation until day 12 
post-ovulation where 332 genes were expressed higher and 42 at lower transcript levels. 
Expression of these genes was validated by real-time RT-PCR. Many of these genes were 
known estrogen-induced genes and genes involved in regulation of estrogen signaling. Genes 
known to be regulated by progesterone and PGE2 were also found. It was concluded that the 
target genes and pathways of conceptus-derived estrogens, progesterone, and  
prostaglandin E2 in the maternal endometrium are involved in the establishment and 
maintenance of pregnancy. 
2.5.1 Effects of Progesterone 
 Progesterone supplementation has been used in animals with low post-ovulatory 
progesterone levels during early pregnancy and in embryo transfer protocols to create a 
synchronous and suitable uterine environment, allowing the embryo to develop thereby 
preventing luteolysis. Progesterone had been called the “hormone of reproduction”, acting 
through its receptor and several co-factors, it orchestrates molecular, biochemical and 
physiological interactions in the uterus that affect embryo growth, development and viability 
(Spencer et al., 2004). 
Rambags (2008) describes detection of mRNA for an equine membrane associated 
progesterone receptor (mPR), intracellular progesterone receptor (PR), and intracellular 
estrogen-β receptors (ERβ). These results suggest that progestins and estrogens may directly 
affect embryonic development in the horse. Therefore it is possible that maternal progesterone 
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stimulates the conceptus to synthesize factors that play a role in maternal recognition and 
continued luteal function during early pregnancy. 
 All three of the major progesterone dependent proteins (uterocalin, uteroglobin, and 
uteroferrin) were detected at various levels throughout pregnancy by immunohistochemistry and 
histological staining of biopsies in pregnant mares (Ellenberger et al., 2008). Uterocalin 
secretions were highest during the peak of progesterone production by the primary corpus 
luteum (days 16-28), then declined. Uterocalin production again increased with a sharp rise 
when endometrial cups were formed (day 40) and again declined when cups began to 
degenerate. These findings agree with previous suggestions that uterocalin is a carrier protein 
that provides the conceptus with essential nutrients for morphogenesis and that it is the most 
progesterone dependent of the three proteins. Uteroferrin did not increase until day 40 when 
endometrial cups formed and continued throughout gestation. Formation of endometrial cups 
also caused a rise in serum estrogen that is thought to stimulate uteroferrin. In ovariectomized 
mares it was reported that administration of progesterone increased uterine secretions of 
uteroferrin and that secretion was also amplified by estrogen (McDowell et al., 1987). 
Uteroglobin was detected in various low levels throughout gestation, suggesting that the 
progesterone/estrogen ratio may be very important in regulating uteroglobin secretion. 
 In cattle, progesterone has been reported to affect the volume of uterine secretions 
(Garrett et al., 1988) and the ability to produce the luteolysis inhibitor interferon-τ (Mann et al., 
2006). Trophoblast protein-1, also known as interferon-τ (IFN-τ) is a glycoprotein secreted by 
the conceptus of cows and sheep between days 17 to 22 of gestation (Geisert et al., 1988). IFN-
τ is antiluteolytic and either inhibits or alters the pattern of endometrial release of PGF2α (Helmer 
et al., 1989a; Helmer et al., 1989b). IFN-τ also exerts antiviral and anti-proliferative activities 
which assist in maintaining pregnancy (Pontzer et al., 1988; Pontzer et al., 1991).   
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 Maternal plasma progesterone concentrations were correlated with IFN-τ  production by 
bovine conceptuses (r=0.593; P <0.006) (Kerbler et al., 1997). It was also noted that there was 
a tendency (P=0.059) for an increase in synthesis of IFN-τ by conceptuses from heifers treated 
with hCG day 5 post-ovulation. Kerbler determined from this study that higher maternal 
progesterone, via human chorionic gonadotropin (hCG) treatment during early pregnancy or 
exogenous progesterone supplementation, provides a more suitable environment for developing 
bovine conceptuses. 
Hicks et al. (2003) investigated the link between IFN-τ and upregulation of uterine Mx 
gene expression in pregnant cows, gilts, and mares. The Mx gene was first characterized in 
sheep in response to upregulation by IFN-τ and providing immune response to viral infection in 
early pregnancy (Horisberger and Gunst, 1991; Ott et al., 1998). Mx gene expression was 
upregulated in cows, gilts, and ewes during early pregnancy (Hicks et al., 2003). There was no 
difference in uterine expression of the Mx gene in pregnant versus non-pregnant mares (Hicks 
et al., 2003). This could be because the equine conceptus does not elongate or secrete IFN-τ 
during ealy pregnancy and fixation and maternal recognition occurs through a different 
mechanism (Baker et al., 1991). 
Lawson and Cahill (1983) treated donor ewes with progesterone for 6 days post-
ovulation and transferred day 10 embryos to progesterone treated ewes (Lawson and Cahill, 
1983). Pregnancy rates at day 25 post-ovulation revealed no difference between the 
progesterone treated ewes receiving asynchronous embryos and ewes that had 10 day old 
embryos transferred 10 days post-ovulation. This suggests that the increased progesterone 
early in the cycle primes the uterus and can accelerate the uterine environment to facilitate 





2.6 Equine Embryo Cryopreservation 
 Equine embryo cryopreservation has the potential to simplify and increase the 
prevalence of embryo transfer in many ways. The ability to cryopreserve embryos allows 
recovery and transfer of embryos to be separated by both location and time, decreasing the 
necessity to synchronize donor and recipient animals. Embryos could be collected and frozen 
from sport mares, allowing production of progeny without interfering with competition schedule. 
The ability to cryopreserve and store equine embryos would enable producers to bank valuable 
genetics similar to what is done other species. International distribution of valuable bloodlines 
could be increased via international trade of frozen embryos in a system similar to that already 
exists for frozen semen and bovine embryos. Despite all of these advantages, the successful 
cryopreservation of equine embryos is a technique has that frustrated researchers and 
practitioners, due to the inability to effectively cryopreserve large equine embryos.  
 Prior to the cryopreservation procedure, embryos must be exposed to cryoprotectants 
(Seidel, 1996). Cryoprotectants are classified as either intracellular (penetrating) or extracellular 
(non-penetrating). Intracellular cryoprotectants typically have low molecular weights allowing for 
cell permeation. Examples of intracellular cryoprotectants include ethylene glycol (EG), glycerol, 
and dimethyl sulfoxide (DMSO).  
Extracellular cryoprotectants have high molecular weights and do not readily penetrate 
embryonic cells. Examples of extracellular cryoprotectants include sucrose, galactose, and 
serum albumin. Various cryoprotectants are frequently used in combination to inhibit the 
negative effects of high concentrations of a single cryoprotectant. It is not uncommon for 
cryoprotectants to be added or removed in a number of equilibration steps to prevent osmotic 





2.6.1 Conventional Slow-Cooling of Equine Embryos 
 During the conventional slow freezing process, embryos are exposed to a low 
concentration of cryoprotectant(s), allowed to equilibrate, loaded into plastic straws, and then 
slowly cooled. As the cooling process progresses ice crystals begin to form in the extracellular 
medium causing the cryoprotectant solution within the embryo to become more concentrated 
and hypertonic as additional water is drawn out of the cells. The typical cooling rate for this 
procedure is -0.5 to 0.6ºC/min (Seidel, 1996). To prevent super cooling (cooling without freezing 
when temperatures are below 0ºC), ice crystal formation is induced (seeding) at approximately -
6ºC. The seeding procedure involves dipping forceps or a cotton applicator into liquid nitrogen 
and then touching the straw with the frozen instrument.  
 Most damage to embryos during the slow cool procedure occurs during the thaw 
process.  Rapid thawing can result in a sudden influx of water into blastomeres causing osmotic 
swelling. To minimize this, cryoprotectants are removed in a stepwise manner by placing 
embryos in decreasing concentrations of extracellular cryoprotectants. This allows the 
intracellular cryoprotectant to be removed from the cells during gradual rehydration. 
The first foal born from a frozen equine embryo was reported in 1982 (Yamamoto et al., 
1982). This study utilized glycerol as a cryoprotectant and only one foal resulted from three 
confirmed pregnancies following the transfer of 11 frozen-thawed early blastocysts.   
Subsequent studies have established that acceptable pregnancy rates (50-60%) can be 
achieved if conventional slow-freezing is used when embryos are cryopreserved at an early 
developmental stage (morula to early blastocyst) and are <300µm in diameter (Czlonkowska et 
al., 1985; Slade et al., 1985; Skidmore et al., 1991; Squires et al., 2003).   
One successful method was reported by Slade and associates (1985). In this study, 
glycerol was used as the cryoprotectant at a concentration of 5% and 10% v/v in a base 
medium of Dulbecco’s phosphate-buffered saline (D-PBS) supplemented with 5% calf serum. 
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Embryos were exposed to 5% glycerol for 10 minutes and then transferred to a 10% glycerol 
solution for 20 minutes. Embryos were then loaded into plastic straws and cooled from 4ºC to    
-6ºC then seeded and held at this temperature for 15 minutes. Temperature was then reduced 
to -33ºC at -0.5 ºC/min before plunging into liquid nitrogen. Embryos were thawed first by 
immersing the straw in a 37ºC water bath for 30 seconds. Embryos removed from plastic straws 
and then moved through solutions of decreasing concentrations (10%, 8.3%, 6.7%, 5.0%, 3.3% 
and 1.6% glycerol v/v) for 10 minutes each, to dilute internal cryoprotectant concentration before 
transfer. In this study 17 blastocysts were transferred, resulting in 9 pregnancies (53%). It was 
also noted that early blastocysts resulted in a higher pregnancy rate (8/10) compared with 
expanded blastocysts (1/7). Various studies have used Slade’s slow-cool protocol with slight 
modifications. Maclellan (2002) reported pregnancy rates of 55% (embryos <250µm) by 
modifying time exposed to cryoprotectant and concentrations of thaw solutions.  
Ethylene glycol is a smaller molecule (27.6Å) than glycerol (90.2Å) and is thought to 
penetrate equine embryos more readily (Pfaff, 1993; Gordiyenko et al., 2004). Bruyas (2000a) 
compared the effects of using 1.5M glycerol to cryopreserve day 6 equine embryos (Treatment 
1) with 1.5M glycerol with the addition of sucrose during thaw media (Treatment 2), 1.5M 
ethylene glycol as cryoprotectant (Treatment 3), and 1.5M ethylene glycol with the addition of 
sucrose in thaw media (Treatment 4). After the freeze/thaw procedure embryos were cultured, 
fixed in glutaraldehyde and serially sectioned and evaluated with light microscopy. None of the 
frozen/thawed embryos treated with ethylene glycol, with or without the addition of sucrose, 
possessed any viable cells (Treatments 3 and 4), however those frozen in glycerol exhibited no 
lysed cells. Sucrose did not affect the number of lysed cells in the glycerol treatment group. The 
results of this study suggest that glycerol is a superior cryoprotectant when compared with 
ethylene glycol for early equine embryos (Huhtinen et al., 2000). In contrast, O’Donovan et al. 
(2000) demonstrated that incubation of large equine embryos (300-600µm) in 2M ethylene 
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glycol for 40 min was more effective than cryopreserving embryos with a higher molar 
concentration of ethylene glycol or step down equilibration.  
Researchers compared the effectiveness of glycerol during slow cooling on blastocysts 
and expanded blastocysts and morulae and early blastocysts to 1,2-propanediol for morula and 
early blastocyst and fresh transferred controls embryos (Meira et al., 1993). This study also 
indicates that glycerol may be a superior cryoprotectant when compared with 1,2-propanediol 
when used for conventional slow cooling. Results also indicated that blastocyst and expanded 
blastocyst (day 7) embryos are unsuitable for cryopreservation via conventional slow cooling.  
Researchers continued evaluating combinations of glycerol and other cryoprotectants 
and combined it with sucrose or 1,2-propanediol and conventionally slow cooled day 6 embryos 
(Ferreira et al., 1997). Pregnancy rates were 13.3% and 0%, respectively, after thawing and 
transfer. Non-transferred embryos from each group were also frozen-thawed and subjected to 
ultrastructural analysis. Both groups contained embryonic cells that were deformed and showed 
dilation of the intercellular and perivitelline spaces. These results indicate that these 
cryoprotectant combinations were not effective against damages caused during the freeze/thaw 
process.  
Numerous cryoprotectants have also been utilized in the effort to find a suitable freezing 
procedure for the larger day-7 equine blastocyst. The probable cause of reduced embryo 
viability during freezing and thawing of large embryos is the disruption of cell organelles, in 
particular the cytoskeleton, as a result of intracellular ice formation (Dobrinsky, 1996). 
MacLellan (2002) investigated using cytochalasin-B (cyto-B) as a pretreatment for large 
embryos to inhibit actin polymerization by temporarily deconstructing the actin filaments. It  has 
been previously shown to reduce cytoskeleton damage during cryopreservation of porcine 
embryos, thereby, possibly improving embryo viability (Dobrinsky et al., 2000). MacLellan et al. 
(2002) reported that equine embryos pre-treated with cyto-B had similar rates of embryonic 
28 
 
vesicle formation as embryos frozen with no pretreatment, indicating cyto-B is not effective for 
cryopreserving large embryos. 
Some success in cryopreserving large equine embryos has been reported. Young 
(1997) utilized large equine embryos (300-680µm) and compared one step addition and serial 
dilution of 1M glycerol, step-down equilibration with 2M glycerol in the presence of galactose in 
media, and standard vitrification protocol with step-wise addition of 11.9M ethylene glycol. 
Embryos incubated in step-down equilibration with 2M glycerol with the addition of galactose in 
the media had higher grades and increased in post-flush diameter. These findings are 
consistent with previous work that demonstrated that equine blastocyst >300µm are more 
sensitive to vitrification damage than smaller blastocysts (Hochi et al., 1995b). Of the embryos 
exposed to 2M glycerol, five were transferred, resulting in two 26-day pregnancies. The 
rationale for step-down equilibration is that high extracellular concentrations of glycerol are 
required to produce effective intracellular concentrations in seemingly impermeable blastocysts; 
however, high concentrations of cryoprotectants in the thawing medium would be detrimental by 
causing cellular lysis (Young et al., 1997). 
2.6.2 Vitrification of Equine Embryos 
 Vitrification is defined as the conversion of liquid rapidly into glass. During the vitrification 
process the equine embryo is placed in high concentrations of various cryoprotectants for a 
short period of time, not allowing equilibration. Media can be placed in organized droplets in a 
tissue culture dish or in a four well plate. Generally, the droplets increase in concentration of 
cryoprotectant(s), with the incubation in the final droplet less than one minute (including the time 
in package prior to plunging in liquid nitrogen. Timing is extremely important to prevent toxic 
effects of the high concentration of cryoprotectants.  
 The first pregnancies from the vitrification of equine embryos was produced by 
subjecting early blastocysts to a 40% ethylene glycol, 18% Ficoll, and 0.3M sucrose solution for 
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2 minutes (Hochi et al., 1994). Single embryos were then loaded into 0.25-ml plastic straws and 
cooled in liquid nitrogen vapor for 1 minute and then immersed in liquid nitrogen. Straws were 
warmed by incubation in warm water (20ºC) for 20 seconds and the contents were then 
expelled into a 0.5M sucrose in PBS. Following in vitro culture for 4 hours, five embryos were 
transferred non surgically into the uterine horn of recipient mares, resulting in two pregnancies. 
 Recently procedures previously utilized in ovine and water buffalo embryo vitrification 
have been modified to facilitate equine embryo vitrification. The first such equine study exposing 
embryos to serial dilutions of cryoprotectants during the thaw process, resulted in a 62% 
pregnancy rate of embryos <300 µm after direct transfer (Caracciolo di Brienza et al., 2004), 
while embryos >300 µm resulted in a 0% pregnancy rate after transfer. Serial dilution 
techniques were then modified for dilution of cryoprotectants in the straw, allowing embryos to 
be directly transferred after thawing into the recipient’s uterus (Eldridge-Panuska et al., 2005). In 
these procedures the vitrification solutions were as follows: VS1 = 1.4M glycerol, VS2 = 1.4M 
glycerol and 3.6M ethylene glycol, VS3 = 3.4M glycerol and 4.6M ethylene glycol. The base 
medium for these solutions was a modified phosphate buffered saline (PBS) as previously 
described (Caracciolo di Brienza et al., 2004). Embryos were placed in VS1 for 5 minutes, VS2 
for 5 minutes, and the total time of exposure to VS3 to plunging into liquid nitrogen <1 minute. 
Embryos were loaded into straws with a dilution solution (DS; 0.5M galactose, 90µl) on either 
side of the embryo, with each solution separated by an air pocket. To thaw, embryos were held 
at room temperature in air for 10 seconds before being plunged in a water bath at 37°C for 10 
seconds. The straws were then “flicked” to ensure mixing of the DS solution with VS3 and 
transferred within 6 to 8 minutes of thawing. Results from these studies indicated that embryos 
>300 µm didn’t produce a viable vesicle in the two-step dilution or direct transfer treatment 
groups. However, embryos <300 µm exhibited acceptable pregnancy rates (>50%) with both 
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thaw procedures and with no difference (P>0.05) between treatments. Similar vitrification media 
kits are now commercially available and allow for embryo cryopreservation. 
The effects of cooling embryos for an extended period of time have also been 
investigated (Hudson et al., 2006). Small embryos (<300 µm) were collected and prepared to be 
vitrified as previously described (Carnevale et al., 2004; Eldridge-Panuska et al., 2005) or 
collected and placed in holding media. Embryos were then cooled to 5ºC and held for 12-19 
hours before vitrification. After thawing all embryos were directly transferred into the uterus of 
recipients. Pregnancy rates at day 16 post-ovulation were not different between the two groups 
(15/20, 75%; and 13/20, 65% respectively). These results indicate that small equine embryos 
could be cooled and stored for up to 19 hours after collection to allow shipping to a facility to be 

















SERUM PROGESTERONE CONCENTRATION AND EMBRYO DIAMETER ON DAY 7           
POST-OVULATION IN MARES 
 
3.1 Introduction 
Monitoring serum progesterone (P4) concentrations has been a routine practice for 
determining phases of the estrous cycle or pregnancy in mares. Pregnancy loss occurs in 10 to 
15% of mares during gestation and the majority of these losses occur during the first 40 days of 
pregnancy (Allen et al., 2001b).  The pregnancy is most vulnerable at this stage because the 
primary CL is the sole source of progesterone. It has been reported that the primary corpus 
luteum should produce systemic blood concentrations of progesterone >4ng/ml the first 3 weeks 
of pregnancy (Dawson el al., 1977).  
Papa et al. (1998) attempted to find predictive attributes of early equine pregnancy to 
determine possible association with early embryonic death. In this study, most embryonic loss 
occurred on day 19 (47%) and day 21 (29%) post-ovulation, in agreement with findings reported 
by Bergfelt et al. (1992) . In these studies, mean embryo diameter and circulating progesterone 
levels did not differ between the pregnant and non-pregnant (early embryonic death) groups, 
suggesting that progesterone decrease is the result of and not the cause of early embryonic 
death in mares. It was also reported that no correlation existed between diameter of the corpus 
luteum and the maintenance of pregnancy in mares. However, mean plasma estrogen 
concentration and embryo vesicle diameter were higher in pregnant mares, and either could be 
an indication of embryo viability.  
Exogenous progesterone supplementation provided to ovariectomized embryo transfer 
and pregnant mares after luteolysis induction has been reported to save and positively stimulate 
mobility, fixation, orientation, and prevent early embryonic loss (Kastelic et al., 1987). In this 
study, it was also demonstrated that embryos could be rescued by progesterone 
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supplementation up to 4 days after prostaglandin treatment. Results from these studies 
demonstrate the importance of progesterone in embryo-uterine interactions in early equine 
pregnancy. 
Administration of exogenous progesterone has been reported to increase fetal weight 
and crown rump length in ewes (Kleemann et al., 1994). Early evidence indicates that 
progesterone treatment changes cell lineage differentiation in sheep, with differences in the 
proportion of inner cell mass and trophectoderm cell number (Hartwich et al., 1995). Kleeman et 
al. (2001) reported that a proportionate increase in fetal growth occurred when ewes were 
supplemented with exogenous progesterone in early pregnancy; specifically affected were the 
kidney, spleen, total gut, head width, and thorax circumference. These authors also reported 
that response to progesterone treatment did not occur when treated the first three days of 
pregnancy, but this effect manifested itself when progesterone supplementation occurred after 
the embryo entered the uterus.  
Similarly in cattle, increasing progesterone from day 2 to 5, produced a 10-fold increase 
in conceptus length at day-14 (Garrett et al., 1988). Kerbler et al. (1997) demonstrated a slight 
increase in interferon-τ production by day-18 bovine embryos collected from cows that were 
supplemented with progesterone around day 8 of pregnancy by induction of accessory corpus 
lutea. The conclusions from these studies are that the post ovulatory progesterone rise and not 
the level of progesterone secretion results from is most important in the control of embryo 
development in the cow. This hypothesis was supported by the finding that progesterone was 
supplementation from day 5-9, but not from day 12-16 post-ovulation, resulted in a six fold 
increase in the uterine concentration of interferon-τ and a fourfold increase in trophoblast length 
on day 16 of pregnancy in cows (Mann et al., 2006). 
Some of the major secretory products that have been identified during early pregnancy 
of the mare include steroids, eicosanoids, proteins, and peptides (Simpson et al., 1999). The 
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first published report of equine conceptus steriodogenesis indicated embryonic production of 
estrogen and androgens (Flood et al., 1979). Goff et al. (1993) suggested that 17α-
hydroxyprogesterone, not estradiol, is the major steroid synthesized by the equine conceptus 
between 7 to 14 days post-ovulation. These researchers also reported that 17α-
hydroxyprogesterone is further metabolized into an unidentified steroid by the endometrium and 
it is thought that these steroids could play a role in conceptus development and embryonic-
uterine cross talk.  
Recently, coexpression of two equine genes (EqIFN-δ1 and EqIFN-δ2) coding for a 
protein similar to the interferon (INF) family, which is the bovine, ovine and porcine signal for 
maternal recognition (Cochet et al., 2009). EqIFN-δ1 and EqIFN-δ2 genes are produced during 
day 16 to 22 of pregnancy in the horse (Cochet et al., 2009), which coincides with the critical 
time of early embryonic loss in the mare. The direct effects of progesterone and/or progesterone 
supplementation have yet to be studied on EqIFN-δ1 and EqIFN-δ2. 
Rambags (2008) described detection of mRNA for an equine membrane-associated 
progesterone receptor (mPR), intracellular progesterone receptor (PR), and intracellular 
estrogen-β receptors (ERβ). This suggests that maternal estrogen and progesterone stimulates 
the conceptus to synthesize factors that may play a role in maternal recognition and continued 
luteal function during early pregnancy. 
There are numerous progesterone-dependent proteins, many of which are vital to the 
nutrition of the equine conceptus that have been reported to be produced by the uterus 
(Betteridge, 2000) and acute loss of these proteins occurs with luteolysis (Zavy et al., 1979b). 
All three of the major progesterone-dependent proteins (uterocalin, uteroglobin and uteroferrin) 
have been detected at various levels throughout pregnancy by immunohistochemistry and 
histological staining of biopsies in pregnant mares (Ellenberger et al., 2008). Uterocalin 
secretions were highest during the peak of progesterone production by the primary corpus 
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luteum (days 16-28), then declined. Production increased again with a sharp rise when 
endometrial cups were formed (day 40) and again declined when cups began to degenerate. 
These findings suggest that uterocalin may be a carrier protein that provides the conceptus with 
essential nutrients for morphogenesis and that it is the most progesterone-dependent of the 
three proteins.  
It has been demonstrated that passive immunization of ferrets with a heterologous anti-
progesterone monoclonal antibody arrests embryonic development during early pregnancy 
(Rider and Heap, 1986). This result indicates that the normal course of pregnancy is arrested as 
a result of antibody binding of progesterone in the circulation, causing a decrease in the amount 
of progesterone available to target cell receptors, blocking normal cleavage and embryonic 
development at an early stage. 
The use of maternal serum progesterone concentration to estimate embryo size would 
be beneficial in determining the proper collection time for equine embryos destined for 
cryopreservation and transfer. Therefore, the objective of this study was to determine if embryo 
diameter was correlated with maternal serum P4 concentration on day 7 post-ovulation. 
3.2 Materials and Methods 
Experimental Animals 
Two experiments utilizing light horse mares of various breeds (n = 40) were used in this 
study.  The mares were in good body condition (5 to 8) and ranged in age from 3 to 18 years 
and  weighed from 440 to 590 kilograms. Two quarter horse stallions of known fertility, ages 9 
and13, were utilized in both experiments. Breeding soundness exams were conducted on both 
stallions prior to the 2010 breeding season to confirm fertility prior to use. All horses were 
housed at the LSU AgCenter Reproductive Biology Center, St. Gabriel, Louisiana where they 
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were allowed access to Bermuda grass and water ad libidum. All procedures were performed in 
accordance with IACUC protocols. 
Estrus Detection and Artificial Insemination 
Estrus detection was performed first with a stallion followed by reproductive tract 
examinations via transrectal ultrasonography with a 5-MHZ linear probe (Model SSD550, Aloka, 
Wallingford, CT) to predict ovulation.  Each donor mare was inseminated with extended fresh 
semen at a concentration of at least 500 million progressively motile cells when a follicle >35 
mm was detected and again every other day until ovulation. On day 7 post-ovulation, a 
nonsurgical embryo collection was performed on inseminated mares by a single technician 
using a standard equine uterine flushing procedure (Imel et al., 1981) with slight modifications.  
Embryo Collection 
Briefly, mares were restrained in stocks and the rectum was excavated of feces. A tail 
wrap was then applied. Transrectal ultrasonography was used to detect and record the corpus 
luteum diameter and verify the uterus was free from inflammation. The perineal area of the mare 
was carefully washed with warm water and clorahexadine solution, rinsed with clean warm 
water, and dried with a clean paper towel. A small piece of wet cotton is inserted into the 
vestibule to remove any additional debris.  
Three liters of lactate ringer supplemented with 0.5% calf serum (Alvarenga et al., 1993) 
was prepared prior to collection and used as lavage media. After applying a sterile shoulder 
length glove with a small amount of sterile lubricating jelly on the dorsal part of hand, the arm 
was introduced into the vagina to identify the external os of the cervix. With the index finger, a 
32 french foley catheter (Agtech Inc., Manhatten, KS) was advanced through the cervical canal 
into the body of the uterus, avoiding any undue dilation of the cervix. The air cuff was inflated 
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with 30 to 50 ml of air and pulled gently back to form a seal with the internal os of cervix. The  
catheter was connected with sterile Y-tubing (Agtech Inc., Manhatten, KS) to the lactate ringer 
and a large-volume filter (EZ-way filter, Reproduction Resources, Walworth, WI). The system 
was purged of air and a total of 2 to 3 L of flushing media was infused and collected via gravity 
flow in aliquots of 500 to 1000 ml. After flushing was completed the system was purged with 
additional flush media to remove any contents from tubing. Flushing media was then searched 
using a stereomicroscope for embryo(s). Individual embryos were identified and then washed 
through three to six drops of Syngro holding media (Bioniche Animal Health, Ontario, Canada) 
to remove any debris. Embryos were then transferred to 500 µl drop of holding media in a four-
well plate. All media were pre-warmed and maintained at 37°C. 
Serum Collection and Evaluation 
Blood samples were collected via jugular venipuncture before artificial insemination (AI) 
(day 0) and again on day 7 post-ovulation. Blood samples were allowed to clot then centrifuged 
for 10 min at 2,600 x g and serum stored at -20°C until assayed.  Samples were collected from 
mares which an embryo was collected (n=23) and noninseminated mares (n = 15) from the 
same research herd on the day of expected AI (day 0) and again on day 7 post-ovulation. 
Serum progesterone was determined using progesterone fluorometric enzyme immunoassay 
(FEIA) (AIA 360, Tosoh Bioscience, Inc., South San Francisco, CA). Embryo diameter was 
measured including the zona pellucida using Micron Software (Westover Scientific, Mill Creek, 
Washington). 
Statistical Analysis 
All data was assessed for normality by Shapiro Wilk test. Log-10 was used to transform 
and normalize all data. A one way analysis of variance (ANOVA) was used to determine 
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differences between progesterone concentration on day 7 post-ovulation for single, double 
ovulation, and control embryos. ANOVA was also used to determine differences between 
progesterone concentration on day 7 post-ovulation for mares from which embryos were 
collected. Embryos were divided into two groups, <400 µm and >400 µm. Embryo diameter, 
progesterone concentration day 7 post-ovulation, and corpus luteum diameter day 7 post-
ovulation differences were analyzed by Pearson correlations Statistics were analyzed using 
statistical software (SigmaStat version 3.5). Significance was set at the P<0.05 level.  
3.3 Results 
Embryo Collection 
 A total of 40 single embryos (608.77µm ± 63.61µm) were collected from 23 mares in this 
study. A total of six pairs of embryos were collected as a result of double ovulation from three 
mares (Table 4.1). Control progesterone concentrations were obtained from 15 single ovulating 
non inseminated mares. Double ovulation control samples were obtained from two 
noninseminated double ovulating mares. Corpus luteum diameters on day 7 post-ovulation were 
recorded for 23 single embryos. 
Experiment 1 
 In this experiment serum progesterone concentrations on day 7 post-ovulation were 
higher (P=0.009) for mares who produced two viable embryos from double ovulation 
(24.17±2.82 ng/ml) compared with mares from which a single embryo (14.04±0.99 ng/ml)  was 
collected and control mares (13.53±1.80 ng/ml) (Figure 3.1). No differences (P=0.91) were 
detected in serum progesterone concentration on day 7 post-ovulation between mares from 


























Figure 3.1 : Progesterone concentrations of single and double ovulating 
mares day 7 post-ovulation. 
 
a,b 






             Mares from which a single embryo was collected were divided into two groups, those 
producing embryos <400 µm and those producing embryos >400 µm. Embryos collected from 
mares that double ovulated and produced two viable embryos had higher mean serum 
progesterone concentration (24.17±2.82 ng/ml) compared with mares producing embryos  
<400 µm (10.78±1.14 ng/ml), >400 µm (15.61±1.28 ng/ml), and control mares (13.53±1.80 
ng/ml), (P=0.001, P=0.065, P=0.012, respectively) (Figure 3.2). Mares producing embryos >400 
µm tended to have higher (P=0.08) circulating progesterone concentrations when compared 
with mares producing embryos <400 µm. However, serum progesterone concentrations day 7 
post-ovulation in mares producing embryos >400 µm and <400 µm were not different (P=0.61 
and P=0.68, respectively) than control mares. 
 Diameter of single embryos were not correlated (r=0.15, P=0.33) with serum 
progesterone levels day 7 post-ovulation. However, single embryos <1000 µm in diameter were 
correlated with serum progesterone concentration day 7 post-ovulation, a significant positive 
correlation was detected (r=0.46, P=0.006) (Figure 3.3). There was no correlation between 
embryo diameter, corpus luteum diameter, or serum progesterone concentration day 7 post-
ovulation (Table 3.1).  
 Mares from which two viable embryos were recovered are summarized in Table 4.2. In 
double ovulating mares embryo diameter and serum progesterone concentration day 7 post-
ovulation were correlated (r=0.70; P=0.01)(Figure 3.4). 
3.4 Discussion 
Measurement of circulating blood progesterone levels has been utilized as a tool to 
differentiate non-pregnant from pregnant mares during early pregnancy (Palmer et. al., 1974). 

























Figure 3.2 : Progesterone concentrations of single and double ovulating 
mares day 7 post-ovulation. 
a,b 





































Figure 3.3: Serum progesterone concentration day 7 post-ovulation in 
single ovulating mares and embryos collected <1000µm in diameter. 












   
Table 3.1 : Pearson correlation results for serum progesterone concentration, embryo               
diameter, and corpus luteum diameter day 7 post-ovulation in mares. 
 P value r R2 
Embryo diameter CL diameter 0.19 0.28 0.08 
 Progesterone concentration 0.56 0.12 0.16 
CL diameter Embryo diameter 0.19 0.28 0.08 
 Progesterone concentration 0.14 0.31 0.10 
Progesterone concentration Embryo diameter 0.56 0.12 0.16 
 CL diameter 0.26 0.31 0.10 
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Table 3.2 Embryo diameter and day 7 progesterone levels for double ovulating mares. 
Mare ID Embryo Diameter (µm) Progesterone Concentration (ng/ml) 
1 284 373 17.22 
1 463 1029 27.58 
1 672 796 28.26 
1 833 1650 34.24 
2 533 724 17.54 
3 496 736 20.16 
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Figure 3.4 : Double ovulating mares serum progesterone concentration on day 





luteum beyond day 12 to 14 (maternal recognition) post-ovulation, whereas nonpregnant mares 
experience a sharp decline in progesterone following the release of prostaglandins from the 
endometrium and soon after return to estrus. The primary corpus luteum has been shown to 
produce systemic blood concentrations of progesterone ranging from 4 to 15ng/ml during the 
first 3 weeks of pregnancy (Dawson et al., 1977).  In our study, mean circulating progesterone 
concentrations were 13.53±1.80 for control mares and 14.04±0.99 for single ovulating mares.  
It has been demonstrated that circulating progesterone concentrations during diestrus 
are higher following double ovulations when compared to single ovulations in Thoroughbred 
mares (Henry et al., 1982; Urwin and Allen, 1983). In our study we demonstrated that circulating 
progesterone concentrations were higher in mares where two embryos were recovered 
compared with mares producing single embryos and control single ovulating mares. Circulating 
progesterone concentrations in mares producing two embryos ranged from 17 to 34 ng/ml in our 
study. Progesterone concentrations for single ovulating mares producing a single embryo >400 
µm tended to be higher than single ovulating mares that produced an embryo <400 µm, but not 
different from non-inseminated control mares.  
Papa et al. (1998) attempted to find predictive attributes of early equine pregnancy to 
determine mechanisms associated with early embryonic death. In this study the mean embryo 
diameter and circulating progesterone concentrations did not differ between the pregnant and 
non-pregnant (early embryonic death) groups. These researchers hypothesized that that the 
decrease in progesterone is the result of and not the cause of early embryonic death. This 
hypothesis would explain the differences noted in our study.  
Papa (1998) also reported that there was no correlation between diameter of the corpus 
luteum and maintenance of pregnancy. Our results are in agreement with Papa (1998) in that 
we also demonstrated there was no correlation between mare corpus luteum diameter, 
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circulating progesterone concentration, and embryo diameter during early pregnancy. However, 
in our study, circulating progesterone, corpus luteum diameter, and embryo diameter were 
recorded from 23 research mares and not an entire horse population at the station.  
However, Bergfelt et al. (1998) described endocrinological and morphological 
relationships between the primary corpus luteum during the estrous cycle of non-pregnant 
maresand functional changes in circulating concentrations of progesterone related to structural 
changes in cross-sectional diameter and luteal echogenicity in pregnant mares until day 13. 
These relationships were derived from retrospective data collected over many studies, resulting 
in a large sample population. 
It has been accepted that the initial formation of the equine blastocyst follows the pattern 
of most mammals which requires large amounts of energy to support the movement of fluid 
through the blastocyst. Lane et al. (2001) demonstrated that the equine morula will take up 
equal amounts of pyruvate and glucose as energy sources. Glucose consumption then 
increases exponentially as the embryo begins enters the blastulation phase. It has been 
demonstrated by Bruck et al. (1997) that endometrial proteins influenced by circulating 
progesterone levels can stimulate glucose metabolism and therefore growth of the blastocyst. 
These studies suggest that higher progesterone during blastulation is important to embryonic 
growth. 
Squires et al. (1985) that the reported mean diameters for embryos collected on different 
days after detection of ovulation were 208 µm at 6 days, 406 µm at 7 days, and 1132 µm at 8 
days; however in this study mares were examined once daily for ovulation, and embryos were 
collected at different times each day. In order to test the accuracy of predicting a true day 7 
embryo we used embryos <1000 µm to represent this population. In our study mare circulating 
progesterone concentration and embryo diameter were correlated in mares producing embryos 
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<1000 µm recovered on day 7 post-ovulation. Circulating progesterone concentration and 
embryo diameter were also correlated in mares producing twin embryos in our study. Embryo 
diameter has not previously been reported to be correlated with circulating progesterone 
concentration and could be valuable in projecting the potential diameter (and therefore stage) of 
embryos prior to non-surgical collection. This would alleviate the need for monitoring ovulation 
via transrectal ultrasonography every 12 hours, in order to collect an embryo suitable for 
cryopreservation (early blastocyst).  
Double ovulations in equids occur in 8 to 35% of estrous cycles, the frequency 
depending on the breed and type of mare, with Thoroughbreds and Warmbloods having the 
highest rate and ponies the lowest (Henry et al., 1982). Accurate detection of such ovulations is 
important because twinning could result in injury and/or death to the mare and foals. Ovulation 
and subsequent detection of conceptuses at an early stage (preferably before day 16 of 
gestation) as a result of double ovulation is a very labor intensive and therefore an expensive 
undertaking. Currently there is a semiquantitative test (Target Equine Progesterone Assay, 
Biometallics, Princeton, New Jersey) that can be used to detect progesterone concentrations in 
whole blood, milk, or plasma. Samples are mixed with reagents and a color is produced 
indicating the progesterone concentration (bright blue <1ng/ml, light blue 1-5 ng/ml, and white 
>5 ng/ml). These tests are currently used in detecting estrus.  
Positive correlations in mare circulating progesterone concentration on day 7 post-
ovulation and single ovulated embryos <1000µm and double ovulated twin embryos recovered 
could be utilized to develop a more sensitive chute-side test similar to the Target Equine 
Progesterone Assay. This would alleviate costs and labor involved with monitoring via 
transrectal ultrasonography of ovulation to collect an embryo at the proper stage for 




USING GLYCEROL3H TO EVALUATE EQUINE BLASTOCYST CAPSULE PERMEABILITY 
4.1 Introduction 
Commercially, equine embryos destined for cryopreservation are collected from mares 
on day 6, at the morula stage, due to the limited success of cryopreservation of large blastocyst 
stage day-7 equine embryos (Slade et al., 1985). The equine embryo enters the uterus on days 
6 and 7 post-ovulation and research has shown that collection of day-7 equine embryos is more 
efficient than collection on day 6 (Squires et al., 1999). Developing a repeatable consistent 
freezing protocol for large day-7 blastocyst stage embryos would increase the overall efficiency 
of the equine embryo transfer procedure.  
An unusual feature of early equine embryonic development is the formation of an 
accellular mucin-like glycoprotein layer, known as the capsule, beneath the zona pellucida on 
days 6 to 7 after ovulation (Flood et al., 1982; Oriol et al., 1993a). The capsule remains intact, 
during the embryo mobility phase, enveloping the embryo until the third week of pregnancy 
(Betteridge, 1989).  
The equine capsule is thought to provide protection for the embryo during the mobility 
phase when the embryo migrates throughout the uterine lumen by myometrial contractions 
(Ginther, 1985). This migration is necessary for the embryo to distribute maternal recognition 
signal, and inhibit prostaglandin secretion from the endometrium which would result in luteolysis 
(Vanderwall, 2008).The capsule consists of fine circumferentially arranged fibrils and is 
homogenous in structure (Flood et al., 1982).  
It is hypothesized that the capsule layer of the day-7 equine embryo is impermeable to 
cryoprotectants (CPAs), (Betteridge et al., 1982; Flood et al., 1982; Pfaff, 1993). A negative 
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correlation between capsule thickness and freezeability has led to the hypothesis that the 
capsule may impede access of CPAs into the embryo proper (Legrand et al., 1999b; Bruyas et 
al., 2000a). Previous work by Pfaff et al., (1993) showed that large equine embryos immersed in 
ethylene glycol and glycerol for various amounts of time would allow water to exit along an 
osmotic gradient but did not equilibrate and re-expand, suggesting that the cryoprotectants did 
not penetrate through the capsule.  
Legrand et al. (2000) attempted to digest the capsule by immersing blastocysts in a 
trypsin solution prior to cryopreservation, which resulted in an unusually high pregnancy rate of 
75% after thawing and transfer to recipient mares. However, other attempts to replicate these 
findings yielded much lower results, 27% and 0% (Legrand et al., 2002; MacLellan, 2002), 
respectively.  
Many fish species have similar cryopreservation complications that have been described 
for equine embryos (Hagedorn et al., 1997). Harvey et al. (1983) quantified the amount of 
DMSO and glycerol that penetrated intact and dechorionated (outer chorion removed) zebra fish 
embryos. Intact and dechorionated zebrafish embryos were exposed to DMSO14C or glycerol3H 
in 1M fish ringer. Isotope uptakes were measured with a liquid scintillation counter and 
converted to percent permeation by volume for each embryo. Permeation of both 
cryoprotectants increased several fold when embryos were dechorionated, indicating that the 
chorion retards the free exchange of solutes. This study demonstrates that use of isotopes to 
measure permeation of various solutes into embryos can be utilized to identify embryonic 
permeability barriers. This also suggests since there are such similarities in zebrafish and 
equine embryonic membranes, similar permeation experiments would be informative when 
applied to equine embryos. 
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The objective of this study was to quantify the amount of glycerol penetrating the equine 
capsule using conventional slow cool (1.4M glycerol) and vitrification (3.4M glycerol) protocols, 
thereby determining if capsule impermeability to cryoprotectants is the limiting factor in 
cryopreservation of equine blastocysts and expanded blastocysts. The second objective was to 
determine if incubation in a conventional slow-cool concentration (1.4M glycerol) over an 
extended period of time (15-120 minutes) would increase overall uptake of cryoprotectant. 
4.2 Materials and Methods 
Experimental Animals 
Two experiments utilizing light horse mares of various breeds (n = 14) were used in this 
study.  The mares were in good body condition (5 to 8), and ranged in age from 3 to 18 years 
and ranged in weight from 444 to 590 kilograms. Two quarter horse stallions of known fertility, 
ages 9 and 13, were utilized in both experiments. Breeding soundness exams were conducted 
on both stallions prior to the 2010 breeding season to confirm fertility prior to use. All horses 
were housed at the LSU AgCenter Reproductive Biology Center, St. Gabriel, Louisiana where 
they were allowed access to Bermudagrass and water ad libidum. All procedures were 
conducted in accordance with IACUC protocols. 
Estrus Detection and Artificial Insemination 
Estrus detection was performed first with exposure to a stallion, followed by reproductive 
tract examinations via transrectal ultrasonography with a 5-MHZ linear probe (Model SSD550, 
Aloka, Wallingford, CT) to predict follicular development and ovulation.  Each donor mare was 
inseminated with extended fresh semen at a concentration of at least 500 million progressively 
motile cells when a follicle >35 mm was detected and again every other day until ovulation. On 
day 7 post-ovulation, a nonsurgical embryo collection was performed on inseminated mares by 
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a single technician using a standard equine uterine flushing procedure (Imel et al., 1981) with 
slight modifications.  
Embryo Collection 
Briefly, mares were restrained in stocks and the rectum was excavated of feces. A tail 
wrap was then applied. The perineal area of the mare was carefully washed with a warm water 
and weak clorahexadine solution, rinsed with clean warm water, and dried with a clean paper 
towel. A small piece of wet cotton was then inserted into the vestibule to remove any additional 
debris.  
Three liters of lactated ringer’s supplemented with 0.5% calf serum (Alvarenga et al., 
1993) was prepared prior to collection and used as lavage media. After applying a sterile 
shoulder length glove with a small amount of sterile lubricating jelly on dorsal part of hand, the 
arm was introduced into the vagina to identify the external os of the cervix. With the index finger, 
the external os was dilated by massage to facilitate passing a 32 French foley catheter (Agtech 
Inc., Manhatten, KS) into the body of the uterus. The air cuff was inflated with 30 to 50 ml of air 
and pulled gently back to form a seal with the internal os of cervix. The foley catheter is 
connected with sterile Y-tubing (Agtech Inc., Manhatten, KS) to the lactated ringer’s solution and 
to a large-volume filter (EZ-way filter, Reproduction Resources, Walworth, WI). The system was 
purged of air and a total of 2 to 3 L of flushing media was infused and collected via gravity flow 
in aliquots of 500 to 1000 ml. After flushing was completed the catheter was removed and the 
system was purged with additional flush media to remove any contents from tubing. Flushing 
media was then searched using a stereomicroscope for embryo(s). Individual embryos were 
identified and then washed through three to six drops of holding media (Syngro, Bioniche 
Animal Health, Ontario, Canada) to remove any debris. Embryos were then transferred to a 500 
µl drop of Syngro in a four well plate. All media was pre-warmed and maintained at 37°C. 
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Preliminary Experiments   
A 10ml aliquot of 1.4M glycerol was prepared in PBS with a osmolarity of 1700 mmol/kg 
(hyperosmotic). Holding media with a osmolarity of 287 mmol/kg was used as a hypoosmotic 
solution. All solution osmolarities were validated before use with vapor pressure osmometer 
(Vapro 5520, Wescor, Inc., Logan, Utah). 
Five equine embryos were collected as previously described. After collection, embryos 
were washed through five drops of holding media to remove any debris. Three of these embryos 
were then incubated in a 1.4M glycerol for 720 minutes.  
A diode laser class I 1,480 nm, infrared, solid state (Hamilton Thorne XYClone®, 
Hamilton Throne Biosciences, Beverly, MA) and software was used for laser ablation and/or 
monitoring volume changes for all embryos in this preliminary study. This system includes a 40X 
objective, digital video camera (Lumenera 2.0, Lumenera Corporation, Lawrenceville, GA), laser 
software and a laptop computer. The high transmission, visible infrared, long distance laser 40X 
objective was attached to a Nikon inverted microscope. Embryo volume changes were 
monitored by taking measurements at the 12 to 6 o’clock and 3 to 9 o’clock positions at 
exponential time intervals and averaged and converted to volume for each embryo. 
Measurements were recorded on a 10X objective and translated from pixels into micrometers. 
One embryo received a rent in its capsule after treatment with laser (XYClone®, Hamilton 
Thorne, Beverly, MA) on full power (100% power, 3000 µs pulse).   
 Osmotic response of two additional embryos (early blastocyst with no capsule and 
expanding blastocyst with a developing capsule) were monitored in both hypertonic and 
hypotonic solutions. Individual embryos were exposed to 1.4M glycerol (1700 mmol/kg) for 128 




Experiment 1 – The Effect of Glycerol3H Concentration on Equine Capsule Permeability 
Embryo Transportation 
All embryos were collected at the Reproductive Biology Center, St. Gabriel, LA as 
previously described and transported to the Biology Building on the main Louisiana State 
University campus, Baton Rouge, LA for further processing. All medium was warmed to 37°C 
before use and a portable incubator (Model 19180, Minitube, Verona, WI) was used to maintain 
a constant temperature of 37°C. Individual embryos were transferred from holding media in a 
four well plate to 1.5-ml microcentrifuge tubes (VWR, Batavia, IL) filled with 1.2 ml holding 
medium. The individual embryos were aspirated into a 0.25-ml plastic straw attached to a 1-ml 
syringe for transfer into the microcentrifuge tube. The end of the open end of the straw was 
inserted 1 to 2 cm into medium in a microcentrifuge tube and the embryo was slowly expelled. 
During explusion, the microcentrifuge tubes were held in front of a light source to allow 
visualization of the embryo exiting the straw. After being placed in microcentrifuge tube, the 
embryo descended to the bottom of the tube. The tube was filled then with holding media and 
closed. After the top of the microcentrifuge tube was secured, a strip of parafilm was wrapped 
around the cap to prevent leaks. A 50-ml conical tube was used as a second container. The 50-
ml tube was filled with PBS. The vial containing the embryo was then placed within the 50-ml 
tube and sealed. The 50-ml tube lid was then firmly wrapped with parafilm and placed in 37ºC 
incubator for transport. All embryos were transported to the Galvez laboratory located on 
Louisiana States University’s main campus where Experiments 1 and 2 were conducted. 
Experimental Design 
 Embryos (n=30) were randomly assigned to two treatments. Treatment 1 (n=15) 
consisted of embryos being incubated in 1.4M glycerol with a specific activity of 10µCi for 15 
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minutes. Treatment 2 (n=15) consisted of embryos being incubated in 3.4M glycerol with a 
specific activity of 20µCi for 15 minutes.  
Embryo Incubation in Glycerol3H 
After transportation, cryovials were removed from packaging material and slowly tilted 
back and forth to allow embryos to float from the bottom of the tube. The contents of the tube 
were then poured into a tissue culture dish. The tube was thoroughly rinsed with holding media 
and contents were emptied into a separate tissue culture dish. Once the embryo had been 
located it was evaluated and is held at room temperature in holding medium until incubation in 
labeled glycerol. 
Incubation solutions were prepared by mixing PBS and glycerol (Sigma, St. Louis, MO) 
to obtain a concentration of 1.4M and 3.4M glycerol. This solution was then mixed 1,2,3-3H 
glycerol (American Radiolabeled Chemicals Inc., St. Louis, MO) to obtain a final specific activity 
of 10 µCi/1000 µl. Solutions were stored at -20ºC until use. 
Embryos were incubated in a 500-µl drop of 1.4M or 3.4M tritiated glycerol with a 
specific activity of 10 µCi/500 µl for 15 minutes. After incubation embryos were washed three 
times in 500 µl of unlabeled glycerol identical to the treatment concentration to remove the 
labeled glycerol from the capsule’s surface. All samples were transferred to 1.5-ml micro-
centrifuge tubes (VWR, Batavia, IL) and incubated overnight in 400 µl of nitric acid at 37°C to 
disintegrate embryos. After incubation, vials were vortexed for two minutes and 350 µl of the 
supernatant was transferred to a scintillation vial and mixed with 5 ml scintillation fluor (Ultima 
Gold, Perkin Elmer, Shelton, CT). Samples were then counted on a liquid liquid scintillation 
Counter (TriCarb 3100TR, Perkin Elmer, Shelton, CT) with 65% counting efficiency for tritium. 
Results were expressed in disintegrations per minute (DPM).  
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The volume of each embryo was calculated and multiplied by the number of DPM in 1 
µCi of solution. This yielded the expected maximum number of DPM for each embryo based on 
its volume. The actual DPM of each embryo was divided by its expected DPM to yield percent 
permeation for each embryo expressed in percent. 
Statistical Analysis 
Results were then converted from disintegrations per minute to percent uptake of 
labeled glycerol by volume of the individual embryo. All data was assessed for normality by 
Shapiro Wilk test. Data was normalized using a LOG-10 transformation and differences were 
detected by Student’s T-Test. Differences were detected at the (P<0.05) level. 
Experiment 2 - The Effect of Time on Glycerol3H Permeation in Equine Embryos 
Embryo Incubation in Glycerol3H 
Eleven equine embryos were collected and transported as previously described. After 
transportation cryovials were removed from the packaging material and slowly tilted back and 
forth so the embryo will float from the bottom of the vial. The contents of the vial were then 
poured into a tissue culture dish. The vial was thoroughly rinsed with holding media and 
contents were emptied into a separate tissue culture dish. Once the embryo had been located it 
was evaluated and held at room temperature in holding medium until incubation. 
Incubation solutions were prepared by the addition of PBS to glycerol (Sigma, St. Louis, 
MO) to obtain a concentration of 1.4M and 3.4M glycerol. This solution was then mixed 1,2,3-3H 
glycerol (American Radiolabeled Chemicals Inc., St. Louis, MO) to obtain a final specific activity 
of 10  µCi/1000 µl. Solutions were stored at -20ºC until use. 
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Embryos were randomly assigned to incubation in a 500-µl drop of 1.4M glycerol3H with 
a specific activity of 10 µCi/500 µl for 15 minutes (n=1), 30 minutes (n=2), 60 minutes (n=5), and 
120 minutes (n=3).  After incubation embryos were transferred to 100-mm nylon filters (BD 
Falcon, Franklin Lakes, NJ) and washed using a filtration apparatus with 5 ml of unlabeled 1.4M 
glycerol.  
 All samples were then transferred to 1.5 ml-cryovials and incubated overnight in 400 µl 
of nitric acid at 37°C to disintegrate embryos. After incubation, vials were vortexed for two 
minutes and 350 µl of the supernatant was transferred to a scintillation vial and mixed with 5 ml 
scintillation fluor (Ultima Gold, Perkin Elmer, Shelton, CT). Samples were then counted on a 
TriCarb 3100TR liquid scintillation counter (Perkin Elmer, Shelton, CT) with 65% counting 
efficiency for tritium. Results were expressed in disintegrations per minute (DPM).  
The volume of each embryo was calculated and multiplied by the number of DPM in 1 
µCi/µl of radiolabelled glycerol solution. This yielded the expected maximum number of DPM for 
each embryo based on its volume. The actual DPM obtained from each embryo was then 
divided by its expected DPM to yield percent permeation for each embryo expressed as a 
percentage. 
Statistical Analysis 
Results were then converted from disintegrations per minute to percent uptake of 
labeled glycerol by volume of the individual embryo. All data was assessed for normality by 
Shapiro Wilk test. Data was normalized using a LOG-10 transformation and differences were 







 All three embryos used in the first preliminary experiment responded to placement in the 
hypertonic solution with a rapid decrease to ~45% of their original volume during the first 32 
minutes (Figure 4.1). After 32 minutes two expanded blastocysts with intact capsules (533µm 
and 724µm diameter) began to slowly increase to ~60% of their original volume between 32 and 
64 minutes. Between 128 and 720 minutes the intact embryos decreased to 55% of their 
original volume (Figure 4.2). The compromised embryo exhibited the same rapid decrease 
during the first 32 minutes of incubation shrinking to 45% of its original volume. The steady 
decrease continued between 32 to 720 minutes of incubation and never exhibited any signs of 
re-expansion. After incubation for 720 minutes the compromised embryo was 30% of its original 
volume.  
In preliminary experiment 2 the expanded blastocyst (328 µm in diameter) response to 
hyperosmotic and then hypotonic solutions paralleled that of the early blastocyst (204 µm in 
diameter) but at a decreased expansion level (Figure 4.3). Both embryos decreased rapidly 
once placed in the hypertonic glycerol solution, however the early blastocyst began to 
equilibrate and increase slowly in volume from 57% at four minutes to 86% at 128 minutes post-
exposure. The expanded blastocyst only reexpanded from 21% at 4 minutes to 28% at 128 
minutes post-exposure. After placement in the hypoosmotic both embryos reexpanded rapidly. 
The early blastocyst increased from 86% of its original volume at the beginning of treatment to 
118% at four minutes and declined sharply to 61% by 16 minutes post-treatment. The expanded 
blastocyst increased from 28% of its original volume at the beginning of treatment to 71% at four 







Figure 4.1 : Preliminary experiment 1 -  Osmotic response of equine embryos 724 µm, 533 
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Figure 4.3 : Preliminary experiment 2 -  Osmotic responses of  equine embryos 204 µm 
and 328 µm in diameter incubated in  1.4M glycerol (right of arrow) and holding 




slightly increased from 32 minutes to 128 minutes but decreased again slightly by 720 minutes 
post-treatment. 
Experiment 1 
 In experiment 1 the mean embryo diameter (± standard error mean) following incubation 
in 1.4M glycerol3H  and 3.4M glycerol3H was 696.5 µm ± 108.6 µm and 925.9 µm ± 214.1 µm 
respectively and were not different (P=0.44) (Table 4.1). Percent permeation data was not 
normal when evaluated. Box plot analysis was then used to identify outliers in the data set 
(Figure 4.4). In the 3.4M group, the 314µm embryo exhibited permeation of 79.96%. This 
permeation was more than two standard deviations from the mean of the group classifying it as 
an outlier and subsequently it removed from the data set (Table 4.1).The percent permeation 
between the 1.4M glycerol and 3.4M glycerol were not different (P=0.68) (Figure 4.5).  
Differences in percent permeation were then compared between embryos >400µm and 
<400µm in both the 1.4M and 3.4M groups. With 1.4M treatment, embryos <400 µm had higher 
(P=0.002) permeation compared with embryos >400 µm (8.32% ± 3.85% and 0.35% ± 0.11%, 
respectively) (Figure 4.6). 
Experiment 2 
Data is presented for all samples in Table 4.2. The 60 and 120 minute incubations  
did not differ in diameter (607.2 µm ± 112.2 µm and 914.0 µm ± 498.4µm, respectively). When 
percent permeation was compared no difference (P=.262) was detected between 60 minute 







Table 4.1 : Experiment 1 - Equine embryo permeability when incubated in 1.4M or 3.4M 
















307 0.44 314* 79.96* 
344 5.43 406 0.51 
373 8.70 418 2.64 
435 0.87 571 7.34 
514 0.95 582 0.25 
554 0.37 642 0.57 
567 0.02 672 0.67 
659 0.60 711 0.40 
796 0.16 786 0.49 
833 0.17 1160 0.37 
1120 0.13 1448 0.06 
1338 0.18 1650 0.79 
1616 0.05 3318 0.75 
Mean±SEM 696.5 ± 108.6 2.6 ± 1.4  925.6 ± 214.1 1.2 ± 0.5 
















































Figure 4.5 : Experiment 1 - Mean percent permeation of equine embryos incubated in 
glycerol
3H



























Figure 4.6 : Experiment 1 - Mean percent permeation for embryos  <400µm vs. 
>400µm in diameter incubated in glycerol3H for 15 minutes.  
























Table 4.2 Experiment 2 - Effect of incubation time on 1.4M glycerol permeation 
15 minutes1 30 minutes1 60 minutes1 120 minutes1 
0.0045 0.0010 0.0006 0.0042 
 0.0072 0.0092 0.0024 
  0.0060 0.0040 
  0.0080  
  0.0062  




 These experiments characterized the osmotic behavior of equine embryos in response 
to incubation in varying osmotic solutions. Osmotic responses of bovine (Széll et al., 1989), 
caprine (Seidel, 1989), equine (Pfaff, 1993; Barfield et al., 2010), porcine (Men et al., 2005), and 
ovine (Széll et al., 1989) embryos in various osmotic solutions have also been reported. Sźell et 
al. (1989) demonstrated that in hypertonic solutions of permeating solutes permeation and the 
process of osmotic equilibration begins immediately after the embryo comes into contact with 
the solution and is visualized as a rapid decrease followed by a gradual increase in volume. The 
extracellular osmotic pressure is counteracted not only by volume loss of the embryo, but also 
by the permeating solute. The equilibration of embryos after volume loss is the result of 
cryoprotectant permeation. Sźell et al. (1989) concluded that the more permeable an embryo is 
to a cryoprotectant the less initial volume loss occurs. These findings define the processes that 
occurred after subjecting equine embryos to the hyperosmotic glycerol solution. 
Preliminary results in our study demonstrated that equine embryos do exhibit the same 
rapid loss of volume when placed in hyperosmotic cryoprotectant solutions as have been 
reported in other domestic species. However, this initial volume was never fully recovered, even 
when incubated for extended periods of time. Equine embryos possess the ability to respond to 
hyperosmotic and hypoosmotic solutions (collapse and equilibration of the blastocoel cavity), 
indicating that there is some fluid movement across the capsule membrane with the embryos in 
our study. 
Various studies have reported that ethylene glycol may be more permeable than glycerol 
in bovine (Széll et al., 1989), equine (Pfaff et al., 1993), and ovine (Széll et al., 1989) embryos. 
Pfaff et al. (1993) incubated equine embryos of various sizes (<250 µm, 250 to 500 µm, and 
>500 µm) in either ethylene glycol and glycerol for 20 minutes. Embryos <250µm and embryos 
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between 250-500µm incubated in ethylene glycol rapidly lost 50% of their original volume but 
regained 80% after 20 minutes of incubation. This trend is similar to that found in bovine and 
ovine embryos (Széll et al., 1989). Medium-sized embryos incubated in glycerol decreased to 
40% of their original volume by two minutes post-incubation and volume did not change after 10 
minutes. Embryos >500 µm exhibited a steady decline in volume over the 20 minute incubation. 
These results are similar to the ones observed by Barfield et al., (2010) and in our study. 
Barfield et al. (2010) evaluated the osmotic response of equine embryos 300 to 600µm 
(with and without capsules) when incubated in 0.75M ethylene glycol + 0.75M methanol, 1.5M 
methanol, or 1.5M glycerol. Upon removal of the capsule and before applying a treatment, 
embryos lost an average of 22% of their original volume and did not fully recover to 100% of its 
initial volume. Embryos incubated in 0.75M ethylene glycol + 0.75M methanol with capsules 
initially lost 30% of their original volume but then recovered to 92% of original volume at the end 
of 60 minutes. Embryos without a capsule initially lost ~15% of their volume and returned to 
87% of initial volume. When embryos were incubated with intact capsules in 1.5M methanol, 
volume initially increased 10%, and then decreased to 95% original volume after 1 hour. 
Embryos without capsules remained 5% larger when incubated in 1.5M methanol. Barfield et al., 
(2010) incubated equine blastocysts in 1.5M glycerol. Embryos with capsules decreased to 40% 
of original volume within 2 minutes and did not recover any volume during incubation, while 
embryos without capsules decreased to 75% of their original volume gradually over 60 minutes.   
These results agree with findings in our study. However, volume of all intact embryos 
used in our study began to regain volume after 60 minutes of incubation in 1.4M glycerol, this 
may be attributed a shorter incubation time in previous studies. This slight influx could be 
glycerol slowly permeating into the embryo causing an increase in volume. This study is the first 
to incubate equine embryos in cryoprotectant solutions for longer than 60 minutes. The embryo 
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with a compromised capsule behaved similar to those of Barfield et al. (2010) in that volume 
constantly declined throughout the experiment. These experiments suggest that the equine 
capsule may impede movement of glycerol into the embryo.  Because glycerol is a larger 
molecule when compared to ethylene glycol (Gordiyenko et al., 2004), it may cross the capsule 
of large equine embryos less rapidly (Pfaff et al., 1993). 
Numerous cryoprotectants have been utilized in the effort to find a suitable freezing 
procedure for the larger day-7 equine blastocyst.  Glycerol is commonly used in equine embryo 
cryopreservation at different concentrations depending on freezing protocol, 1.4M is typically 
utilized for slow freezing (Poitras et al., 1994; Young et al., 1997) and 3.4M is typically utilized 
for vitrification (Eldridge-Panuska et al., 2005; Hudson et al., 2006).  
Some success in cryopreserving large equine embryos has been reported. Young et al. 
(1997) utilized large equine embryos (300 to 680µm) and subjected them to step-down 
equilibration with 2M glycerol supplemented with galactose. In this study embryos subjected to 
this treatment possessed higher grades post thaw and also increased in diameter when 
compared to post-flush diameter, indicating growth in vitro. Young et al. (1997) also subjected 
large embryos to vitrification concentrations of cryoprotectant and none of the embryos were 
reported to be viable post-thaw. These findings are consistent with previous work that 
demonstrated that equine blastocyst >300µm are more sensitive to vitrification damage than 
smaller blastocysts (Hochi et al., 1995b).  
In our study using large equine blastocysts, 3.4M glycerol was less permeable than 1.4M 
glycerol. This finding supports work reported by Hochi et al. (1995) and Young et al. (1997) and 
demonstrates that limited success of conventional cryopreservation and lack of success in the 
vitrification of large embryos may be due, in part, to the permeability of the two solutions. The 
probable cause of reduced embryo viability during freezing and thawing of large embryos is the  
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disruption of cell organelles, in particular the cytoskeleton, as a result of intracellular ice 
formation (Dobrinsky, 1996). 
Studies have shown that acceptable pregnancy rates (50-60%) can be achieved with 
conventional slow-freezing of embryos at an early developmental stage (morula to early 
blastocyst) that are less than 300 µm in diameter (Czlonkowska et al., 1985; Slade et al., 1985a; 
Skidmore et al., 1991; Squires et al., 2003). This demonstrates that embryos <250 µm 
equilibrate more readily and allowing cryoprotectant solution into protect cells during the 
freeze/thaw process (Pfaff et al., 1993; Barfield et al., 2010). In our study, embryos <400µm 
exhibited more permeation when subjected to 1.4M glycerol than embryos >400µm. These 
findings suggest that small equine embryos allow more cryoprotectant to permeate into the 
embryo and protect cells.  
The equine embryo enters the uterus 6 to 6.5 days post-ovulation (Battut et al., 1997) at 
the late morula or early blastocyst stage completely enveloped in the zona pellucida (Betteridge 
et al., 1982). During the next 24 hours blastulation and the blastocyst capsule begins to form 
and  is primarily produced  by the trophoblast cells and is composed of a mucin-like glycoprotein 
(Oriol et al., 1993b). The capsule is completely formed by day 7 post-ovulation at the blastocyst 
stage (Flood et al., 1982).  
In experiment 1, 1.4M samples were divided comparing samples without a developed 
capsule and samples with a fully developed capsule (<400 µm and >400 µm respectively). 
Embryos without a developed capsule (<400 µm)  took up more labeled glycerol solution than 
embryos with a developed capsule (>400 µm) (P=0.002) possibly due to a lack of, or thin 
capsule, and support previous studies (Pfaff et al., 1993; Legrand et al., 2002; Duchamp et al., 
2006; Barfield et al., 2010). Furthermore, larger equine embryos (>400 µm) allowed <2% 
cryoprotectant permeation by volume indicating that embryos are composed of 98% water when 
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cryopreserved. This high water content increases the chance of ice crystal formation and 
intracellular ice damage, resulting in non-viable embryos. Our results provide quantitative data 
that suggest that the capsule may be the cryoprotectant permeability barrier, therefore causing 
limited success in the cryopreservation of large equine embryos. 
 Permeation of glycerol14C into fertilized and unfertilized mouse ova occurs at a constant 
rate and took up to 200 minutes for equilibration to complete (Jackowski et al., 1980). Our 
results show no differences in percent permeation between 60 and 120 minutes of incubation in 
1.4M labeled glycerol. Total permeation was less than 0.05% across all treatments. Percent 
permeation was higher in experiment 1 were higher than those obtained from experiment 2. 
This may have been a result of different washing techniques used in each procedure following 
incubation. This washing procedure was adapted from previous work conducted in the same 
laboratory testing the effects and permeability of radiolabelled nicotine in zebrafish embryos 
(Thomas et al., 2009). Zebrafish embryos are also encased two protective layers, the chorion 
and yolk syncytial layer (Harvey et al., 1983; Kimmel et al., 1995). It has been demonstrated 
that both layers are durable and resistant to cryoprotectant permeation (Harvey et al., 1983). 
The physical structures of embryos processed by Thomas et al.,(2009) were easily visualized 
with the naked eye and unaffected during the washing procedure. However, the wash procedure 
in experiment 2 did not allow the visualization of equine embryos after processing. Therefore, 
the results indicate that the embryos may have been compromised, resulting in the loss of 
radiolabelled cryoprotectant. Any breach in capsule membrane would have resulted in the 
accelerated loss of glycerol3H due to the increased temperature during processing as 
demonstrated in mouse ova by Jackowski et al.,(1990). 
 Advancements in equine embryo cryopreservation have been restricted by the limited 
success of cryopreserving large day 7 blastocyst. The lack of success has been attributed to the 
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formation of the capsule membrane around the embryo day 7 post-ovulation (Legrand et al., 
2000). Our data demonstrates that glycerol more readily permeates into embryos <400µm that 
do not possess a functional capsule compared with embryos >400µm with a fully formed 
capsule. This suggests that the capsule membrane is the cryoprotectant permeability barrier 
























CONCLUSION AND SUMMARY 
 Cryopreservation of embryos allows genetics to be spread across a greater population 
when compared to natural service and pregnancy. Collecting and cryopreserving equine 
embryos on day 7 post-ovulation would increase the overall efficiency of the cryopreservation 
procedure.  Lack of success has been attributed to blastocyst capsule formation (Oriol et al., 
1993b) which is completely formed by day 7 post-ovulation at the blastocyst stage (Flood et al., 
1982). Studies have shown that acceptable pregnancy rates (50-60%) can be achieved if 
conventional slow-freezing is used, embryos to be cryopreserved are at an early developmental 
stage (morula to early blastocyst), and embryos are less than 300µm in diameter (Czlonkowska 
et al., 1985; Slade et al., 1985a; Skidmore et al., 1991; Squires et al., 2003). 
Results from our preliminary study (Chapter 4) expressed in our study show that equine 
embryos do exhibit the same rapid loss of volume when placed in hyperosmotic cryoprotectant 
solutions as seen in other domestic species (Széll et al., 1989; Seidel, 1989; Men et al., 2005). 
Volume of all intact embryos used in our study began to regain volume after 60 minutes of 
incubation in 1.4M glycerol which differs from previous studies (Barfield et al., 2010). This could 
be attributed to a shorter of duration of incubation in previous observations. This slight influx 
could be glycerol slowly permeating into the embryo causing an increase in volume. This study 
is the first to incubate equine embryos in cryoprotectant solutions for longer than 60 minutes. 
These experiments suggest that the equine capsule may impede movement of glycerol into the 
embryo.   
Numerous cryoprotectants have been utilized in the effort to find a suitable freezing 
procedure for the larger day 7 equine blastocyst.  Glycerol is commonly used in equine embryo 
cryopreservation at different concentrations depending on freezing protocol, 1.4M (Poitras et al., 
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1994; Young et al., 1997) and 3.4M (Eldridge-Panuska et al., 2005; Hudson et al., 2006) In our 
study utilizing large equine blastocysts, 3.4M glycerol was less permeable than 1.4M glycerol. 
This finding supports worked reported by Hochi (1995) and Young (1997) and demonstrates the 
lack of success in the vitrification of large embryos may be due to the poor permeability of the 
cryoprotectant solutions. 
In our study, embryos <400 µm exhibited higher permeation when subjected to 1.4M 
glycerol3H compared with embryos >400 µm (Chapter 4, experiment 1). These results suggest 
that smaller equine embryos without a capsule or possess a thin capsule can allow a sufficient 
amount of cryoprotectant to permeate into the embryo and protect cells.  
 Based on our results we concluded that time had no effect on the uptake of 1.4M 
glycerol3H (Chapter 4, experiment 2). Results from experiment 1 were higher than those 
obtained from experiment 2 and may have been a result of different washing techniques used 
between experiments. 
 We showed mean circulating progesterone concentrations of 13.53 ± 1.80 for control 
mares and 14.04 ± 0.99 for single ovulating mares which are in agreement with previous work 
by Dawson et al. (1977). Circulating progesterone concentrations were higher in mares where 
two embryos were recovered compared with mares producing single embryos and control single 
ovulating mares. Circulating progesterone concentrations in mares producing two embryos 
ranged from 17 to 34 ng/ml in our study. Progesterone concentrations of single ovulation 
producing a single embryo >400 µm tended to be higher than single ovulating mares that 
produced an embryo <400 µm, but not different from noninseminated control mares (Chapter 3).  
We also demonstrated there was no correlation between mare corpus luteum diameter, 
circulating progesterone concentration, and embryo diameter during early pregnancy which 
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agrees with results described by Papa (1998). However, in our study, circulating progesterone, 
corpus luteum diameter, and embryo diameter were recorded from 23 research mares and not 
an entire population. Mare circulating progesterone concentration and embryo diameter were 
correlated in mares producing embryos <1000 µm recovered on day 7 post-ovulation, in our 
study. Circulating progesterone concentration and embryo diameter was also correlated in 
mares producing twin embryos in our study. Embryo diameter has not been correlated with 
circulating progesterone concentration and could be valuable in projecting the potential diameter 
(and therefore stage) of embryos prior to non-surgical collection. This would alleviate the need 
for monitoring ovulation via transrectal ultrasonography every 12 hours, in order to collect an 
embryo small enough for cryopreservation (early blastocyst).  
Advancements in equine embryo cryopreservation have been restricted by the limited 
success of cryopreserving large day 7 blastocyst. The lack of success has been attributed to the 
formation of the capsule membrane around the embryo day 7 post-ovulation (Legrand et al., 
2000). Our results provide quantitative data that suggest that the capsule may be the 
cryoprotectant permeability barrier, therefore causing limited success in the cryopreservation of 
large equine embryos. This information combined with correlations in mare circulating 
progesterone concentration on day 7 post-ovulation and single ovulated embryos <1000µm and 
double ovulated twin embryos recovered could be utilized to develop a more sensitive chute-
side test similar to the Target Equine Progesterone Assay. This would alleviate costs and labor 
involved with monitoring via transrectal ultrasonography for ovulation to collect an embryo at the 
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